+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Biology, Geography & Health: Chapter 35220

Chapter 35220 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.

Tang, S.D.; Qi, J.; Han, Z.W.; Ming, Z.L., 2003:
Levamlodipine therapy for hypertension after kidney transplantation

Lee, Sang Hee, 1999:
Levantines and Londoners, part II Is the cranial variation in the Levant hominids just too much?

Tiwari, A.; Bhandari, A.; Schlueter, J.; Peabody, J.; Vallancien, G.; Guillonneau, B.; Hinson, C.; Newton, S.; Mueller, D.; Farah, R.; Menon, M., 2001:
Levator Ani Muscle Collar for the continence preservation during conventional and laparoscopic radical prostatectomy

Thor, K.B.; Doherty, P.C.; Bremer, R.E.; Coates, K.; Dolber, P.C., 1999:
Levator ani muscle of the rat Raising awareness of the nomenclature mistake

Delancey, J.; Kearney, R.; Umek, W.; Ashton Miller, J.A., 2003:
Levator ani muscle structure and function in women with prolapse compared to women with normal support

Cervigni, M.; Natale, F.; Fondacaro, L., 2003:
Levator myorraphy

Smith, Edward, 2001:
Level and pattern of DNA sequence variation in the chicken genome

Maciejewski, R.; Kopieniak, M.; Pasternak, K., 2000:
Level changes of oxygen, magnesium, zinc and copper in brain during acute pancreatitis

Berdina, L.; Khusnutdinova, E., 2003:
Level chromosomal variability it the inhabitants of some regions of northeast of republic Bashkortostan as the indicator of ecological condition of region

Benke, S.M.; Sheridan, D., 2003:
Level of CD20 expression and disease activity in chronic lymphocytic leukemia

Gaine, P.C.; Pikosky, M.A.; Martin, W.F.; Bolster, D.R.; Maresh, C.M.; Rodriguez, N.R., 2004:
Level of Dietary Protein Influences Whole Body Protein Turnover Post Exercise in Competitive Endurance Runners

Cassefo, V.; Andrade, D.; Matsudo, V., 2000:
Level of Knowledge about physical activity for the health promotion among students of medicine of the ABC Foundation School of Medicine

Campa, A.; Bansal, S.; Nieto, M.; Nowrouzi, S.; Laird, S.; Baum, M.K., 2004:
Level of Physical Activity Affects Distortion of Body Image

Ríos, A.; Martínez-Alarcón, L.; Ayala-García, M.A.; Sebastián, M.J.; Abdo-Cuza, A.; López-Navas, A.; López-López, A.; Ramírez, E.J.; Muñoz, G.; Camacho, A.; Suárez-López, J.; Castellanos, R.; Rodríguez, J.S.; Martínez, M.A.; Nieto, A.; Ramis, G.; Ramírez, P.; Parrilla, P., 2010:
Level of acceptance of a clinical solid organ xenotransplantation program among personnel in organ transplant-related services in Spanish, Mexican, and Cuban hospital centers

Su, L.J.; Nguyen, S.V.; Nguyen, L.T.; Hinh, P.; Lin, H.Y.; Scribner, R., 2002:
Level of acculturation and the use of alcoholic beverage and tobacco products in Vietnamese American population

Dalton, L.W.; Ely, K.; Page, D.L., 2001:
Level of agreement of twelve community pathologists in evaluating core breast biopsies

Nakahara, S.; Iwashita, T.; Ihara, T.; Nishihara, K.; Abe, R., 1999:
Level of anastomosis does effect anorectal function following low anterior resection for rectal cancer

Rahimkhani, S.; Tran, K.; Wang, Y.; Yao, Z., 2000:
Level of apoC-III mRNA correlates positively to the secretion of triglyceride-rich VLDL from transfected McA-RH7777 cells

Jarosiewicz, B.; Skaggs, W.E., 2002:
Level of arousal during the small irregular activity state in the rat

Konstantinova, N.A.; Matveeva, N.A.; Semenova, E.N.; Konstantinova, N.V., 2000:
Level of cryoglobulins and Leucocytoclastic Vasculitis

Konstantinova, N.A.; Sergeev, U.V.; Grabovskay, V.; Konstantinova, N.V., 2000:
Level of cryoglobulins in serum of patient with atopic dermatitis

Enea, V.; Amico, C.; Pistone, M.; Yakimov, M.M., 2000:
Level of cycloossigenase-2 mRNA expression at various stages of rabbit corneal repair after wound healing treatment

Ploman, F.; Hagglund, L.; Sjoblom, P., 1999:
Level of down-regulation and outcome of IVF/ICSI treatment

Xu, L.; Wang, Y.Xing.; Jonas, J.B., 2010:
Level of education associated with ophthalmic diseases. The Beijing Eye Study

Skolnick, A.J.; Davidson, R.J., 2000:
Level of expectation of reward modulates the eyeblink startle response

Chai, L.; Ma, Y.; Tigges, J.; Kouttab, N.; Maizel, A., 2000:
Level of expression of a novel homeobox gene, Hsal 2, is related to cellular lineage, maturational stage and transformation

Araujo, H.A.; Stoddard, J.; Kariyawasam, K.; Gutierrez, M.; Mulder, A.; Lee, J.H.w; Tongio, M.M.; Schreuder, G.M.T.; Yunis, E.; Ng, J.; Hartzman, R.; Fernandez Vina, M.A., 2002:
Level of expression of multiple HLA-A molecules by flow cytometry with monoclonal antibodies labeled with a single fluorescent dye

Anastasio, P.; Cirillo, M.; Spitali, L.; Frangiosa, A.; Pollastro, R.M.; D.S.nto, N.G., 2001:
Level of hydration and renal function in healthy humans

Akkerhuis, M.; Roth, U.; Hoffmann, J.; Brickl, R.; Simoons, M.L., 2000:
Level of inhibition of platelet aggregation predicts outcome of patients treated with the oral glycoprotein IIb/IIIa receptor antagonist lefradafiban Results from FROST

Roth, U.; Hoffmann, J.; Nehmiz, G.; Akkerhuis, K.M.; Brickl, R.; Baardman, T.; Simoons, M.L., 2000:
Level of inhibition of platelet aggregation predicts outcome of patients treated with the oral glycoprotein IIb/IIIa receptor antagonist lefradafiban Results from the Fibrinogen Receptor Occupancy STudy

Levene, S.; Clancy, T., 2000:
Level of interest among Ashkenazi Jewish women, who have no family history of breast cancer, in genetic testing for breast cancer susceptibility

Hagen, K.B.; Bjorndal, A.; Kvien, T.K., 1999:
Level of mental distress is associated with general practitioner consultation in patients with chronic but not acute or subacute non-inflammatory musculoskeletal pain

Ranganathan, V.K.; Kuykendall, T.; Siemionow, V.; Yue, G.H., 2002:
Level of mental effort determines training induced strength increases

Lacoste, B.; Dovero, S.; Bioulac, B.; Gross, C.E.; Bezard, E., 2002:
Level of mptp induced neuronal death in mice is affected by stress

Bratasz, A.; Goscinski, I.; Galka, P.; Moskala, M.; Lukiewicz, S., 2002 :
Level of nitric oxide and ceruloplasmin in cerebrospinal fluid and blood in head injuries

Leury, B.J.; Dunshea, F.R., 2003:
Level of nutrition and breed can influence basal and beta-adreneregic stimulated fat mobilization in lambs

Zabina, H.Y.; Muravov, O.I., 1999:
Level of physical activity in Russia

Andrade, E.; Matsudo, V.; Matsudo, S.; Andrade, D.; Araujo, T.; Oliveira, L.; Braggion, G.; Raso, V., 2001:
Level of physical activity in adults, including and excluding walking, according to the knowledge of Agita Sao Paulo Program

Michailov, M.I.; Shahgildyan, I.V.; Esaulkova, A.I.; Kuznetsova, A.E.; Romanenko, V.V., 1999:
Level of postvaccination response against hepatitis B among drug users individuals

Beeghly, M.; Martin, B.; Rose Jacobs, R.; Bellinger, D.; Cabral, H.; Frank, D.A., 2003:
Level of prenatal cocaine exposure and child language outcomes at 95 years of age

Frank, D.A.; Beeghly, M.; Rose Jacobs, R.; Knight, W.G.ant; Posner, M., 2000:
Level of prenatal cocaine exposure and school age language development

Frank, D.A.; Jacobs,; Beeghly, M.; Augustyn, M.; Bellinger, D.; Cabral, H.; Posner, M., 1999:
Level of prenatal cocaine exposure, center based intervention, and Weschler Pre and Primary School Intelligence Scores at four years of age

Dunjic, R.; Elezovic, I.; Stevanovic, L.H., 2001:
Level of protein S and pregnancy

Chiu, C.H.; Poole, G.; Tardif, M.; Turle, R.; Morcos, R., 2001:
Level of quantification for measuring HCB and PCDD/PCDF in soil

Houansou, J.; Capo Chichi, S., 1999:
Level of recovery of financing costs of a pediatric department Determining factors, approaches to solutions

Pampura, A.; Morozova, O.; Pogomiy, N.; Cheburkin, A.; Svjatkina, O., 2001:
Level of release of IL-4 and IL-5 from peripheral blood lymphocytes in children with atopic dermatitis

Pampura, A.; Morozova, O.; Pogomiy, N.; Cheburkin, A.; Svjatkina, O., 2001:
Level of release of interleukin-4 and interleukin-5 from peripheral blood lymphocytes in children with atopic dermatitis

A.A.mad, A.M.; Sarnak, M.J.; Rand, W.; Gregory, D.; Konstam, M.A.; Salem, D.N.; Levey, A.S., 1999:
Level of renal function as an independent predictor of mortality in patients with left ventricular dysfunction

Rezende, G.; Roque, A.M.rie; Gigou, M.; Dussaix, E.; Challine, D.; Samuel, D.; Feray, C., 2001:
Level of replication and genotypes of hepatitis A virus in fulminant and non-fulminant hepatitis

Perez Padilla, A.; Pellon, R., 2003:
Level of response suppression and amphetamine effects on negatively punished adjunctive drinking

Hasin, D.; Liu, X., 2002:
Level of response to alcohol and DSM-IV alcohol dependence subtypes

Morgan, D.; Hsu, Y.; Stoffel, J.; Dunn, R.L.; Nagel, S.; Fenner, D.; D.L.ncey, J.O.; Mcguire, E.J.; Wei, J.T., 2004:
Level of sexual function is adversely affected by urinary incontinence

Kinikli, G.; Ates, A.; Turgay, M.; Aydogan, N.; Tokgoz, G., 2001:
Level of soluble Fas antigen in patients with allergic rhinitis Its relation to T-cell anergy induced by specific immunotherapy

Haratym Maj, A.E.; Wawrzycka, B.; Luty, S.; Wawrzycki, B.; Cioczek, P., 1999:
Level of soluble L-selectin in premature delivery

Blankenberg, S.; Rupprecht, H.J.ergen; Bickel, C.; Hottkowitz, C.; Lehmann, M., 2000:
Level of soluble vascular cell adhesion molecule and soluble intracelluar adhesion molecule predict future cardiovascular mortality and myocardial infarction in patients with angina pectoris

Korhonen, P.; Kyrylenko, S.; Tapiola, T.; Suuronen, T.; Salminen, A., 1999:
Level of transcriptional repressor protein mSin3A is upregulated during neuronal apoptosis

Blankenberg, S.; Tiret, L.; Poirier, O.; Rupprecht, H.J.; Bickel, C.; Hafner, G.; Meyer, J.; Cambien, F., 2000:
Level of tumour necrosis factor alpha predicts cardiovascular mortality in CAD patients Evaluation of the interaction with the TNFalpha receptor 1 /G-609T polymorphism

Jones, C.A.; Warram, J.H.; Hanna, L.S.; Scott, L.J.; Krolewski, A.S., 2001:
Level of urinary albumin excretion in normoalbuminuric patients with type 1 diabetes as a marker of susceptibility to nephropathy

Matsuo, H.; Zhang, Y.; Morita, E.; Dekio, S., 2003:
Level of vascular endothelial growth factor is elevated in atopic dermatitis

Karlov, V.A.; Romanova, N.A., 2003:
Level rate and prognostic factors of ischemic stroke with hemorrhagic component

Horine, D.A.; Hadimioglu, B.B.; Bruce, R.H.; Noolandi, J.; Elrod, S.A., 2003:
Level sense and control system for biofluid drop ejection devices

Harbeck, N.; Meisner, C.; Prechtl, A.; Untch, M.; Selbmann, H.K.; Sweep, F.; Graeff, H.; Schmitt, M.; Jaenicke, F.; Thomssen, C., 2001:
Level-I evidence for prognostic and predictive impact of uPA and PAI-1 in node-negative breast cancer provided by second scheduled analysis of multicenter Chemo-N0 therapy trial

Thomssen, C.; Harbeck, N.; Meisner, C.; Prechtl, A.; Untch, M.; Lisboa, B.; Selbmann, H.; Schmitt, M.; Jaenicke, F., 2003:
Level-I evidence for prognostic impact of UPA and PAI-1 in node-negative breast cancer patients Ready for use in clinical routine

Toman, Charles R., 1999:
Leveling apparatus for a cutting head of a mower

Van Schaik, C.P.; Pandit, S., 2004:
Leveling coalitions in primate males Toward an explanation of human egalitarianism

Unger, E.; Pereles,, 2000:
Leveling device especially adapted for use in apparatus for performing light beam guided biopsies and the like

Chertow, Glenn M., 2000:
Leveling the paying field in end-stage renal disease

Steinlage, D.L.e; Myers, B.E., 2003:
Leveling wheel structure for a minimum tillage ripper

Diaz, O.; Sun, G.L.u; Salomon, B.; Von Bothmer, R., 2000:
Levels and distribution of allozyme and RAPD variation in populations of Elymus fibrosus Tzvel

Kivela Rajamaki, M.; Maisi, P.; Srinivas, R.; Tervahartiala, T.; Teronen, O.; Husa, V.; Salo, T.; Sorsa, T., 2003:
Levels and molecular forms of MMP-7 and MMP-8 in diseased human peri-implant sulcular fluid

Chen, C'er.; Chen, J.; Zhao, H.; Xie, Q.; Yin, Z.; Ge, L., 2010:
Levels and patterns of polybrominated diphenyl ethers in children's plasma from Dalian, China

Ricklund,N.; Kierkegaard,A.; McLachlan,M.S., 2010:
Levels and potential sources of decabromodiphenyl ethane and decabromodiphenyl ether in lake and marine sediments in Sweden

Bjork, T.; Ulmert, D.; Becker, C.; Nilsson, J.A.; Berglund, G.; Lilja, H., 2002:
Levels and ratios of PSA-forms and hK2 in plasma discriminate men with prostate cancer from men without cancer up to 20 years before diagnosis

Hayward, S.J.; Gouin, T.; Wania, F., 2010:
Levels and seasonal variability of pesticides in the rural atmosphere of Southern Ontario

Hellou, J.; King, T.; Leonard, J.; Milligan, T.G.; Stellar, S.; Yeats, P.; Zitko, V., 2000:
Levels and source apportionment of polycyclic aromatic hydrocarbons and sulfur heterocycles in sediments and mussels

Lebeuf, M.; Gouteux, B.; Measures, L.; Trottier, S., 2004:
Levels and temporal trends of polyhrominated diphenyl ethers in Beluga whales from the St Lawrence estuary, Canada

You, D.; Wardlaw, T.; Salama, P.; Jones, G., 2010:
Levels and trends in under-5 mortality, 1990-2008

Shoskes, D.A.; Lapierre, C.; Zeitlin, S., 2003:
Levels of 16S bacterial DNA in semen by real time PCR do not correlate with clinical diagnosis or treatment response in category III chronic prostatitis

Bezman, Y.; Rouseff, R.L.; Naim, M., 2001:
Levels of 2-methyl-3-furanthiol and methional and relative levels of -beta-damascenone in the headspace of fresh, pasteurized, and stored orange juice as determined by GC-olfactometry

Xu, Y.; Hingtgen, J.N.; Zhou, F.C., 2000:
Levels of 5-HT and 5-HIAA in tissues of pregnant rats and their fetuses

Chen, G.; Heilbrun, L.K.; Atkins, M.; Covington, C.; Djuric, Z., 2002:
Levels of 8-isoprostanes in breast nipple fluids decline with time in women following low-fat diets

Gupta, S.K.; Chalam, K.V.; Vinjamaram, S.; Pakalinis, V.A., 2002:
Levels of Alpha-V beta-3 Integrin on Proliferating Endothelial Cells of CNV

Mikolajczyk, S.D.; Millar, L.S.; Wang, T.J.; Wolfert, R.L.; Rittenhouse, H.J., 1999:
Levels of B-PSA, a specific form of Free PSA, are higher in BPH-associated transition zone than in either benign or cancerous peripheral zone tissue

Buffon, A.; Liuzzo, G.; Biasucci, L.M.; Ramazzotti, V.; Rigattieri, S.; Comerci, G.; Crea, F.; Maseri, A., 1999:
Levels of C-reactive protein before coronary angioplasty predict outcome in both stable and unstable angina patients

Benboubker, L.; Watier, H.; Domenech, J.; Carion, A.; Cartron, G.; Georget, M.T.; Herault, O.; Desbois, I.; Delain, M.; Bardos, P.; Colombat, P.; Binet, C., 2000:
Levels of CD34+ progenitor cells mobilized into peripheral blood are associated with SDF1 gene variants

Feliu, M.S.; Vidueiros, S.M.; Godoy, M.F.; Pallaro, A.N.; Fernandez, I.; Lopez, C.; Pineiro, A.; Strasnoy, I.; Barbeito, S.; Major, M.; Alvarez, R.; Ramos, O.; Slobodianik, N.H., 2004:
Levels of Copper and Zinc in pediatric critical patients Chen; Xie Zhao Xia; Tan D.R.n; E.A., 2002:
Levels of EPO in the serum of patients with acute leukemia

Ramakrishna, G.; Fornwald, L.W.; Anderson, L.W., 1999:
Levels of GTP-bound K-ras p21 in transformed mouse lung epithelial cells and in mouse lung tumors

Wolf, L.A.; Reed, G.F.; Buggage, R.R.; Nussenblatt, R.B.; Chan, C.C., 2002:
Levels of IL-10 and IL-6 in the Vitreous are Helpful for Differential Diagnosis of Primary Intraocular Lymphoma and Ocular Inflammation

Trezkova, V.; Nedzvedz, G.; Matusevich, L.; Shcharbina, N.Y., 2003:
Levels of IgG and TNF-alpha in cerebrospinal fluid of patients with Herpes zoster

Domenech, J.; Carion, A.; Benboubker, L.; Herault, O.; Roingeard, F.; Degenne, M.; Cartron, G.; Desbois, I.; Colombat, P.; Binet, C., 2002:
Levels of MMP-9 but not SDF-1 after G-CSF mobilization are correlated with mobilizing capacity

A.H.llaq, R.A.; Yasuda, R.P.; Wolfe, B.B., 1999:
Levels of NMDA NR1 cassettes in the post-synaptic densities of rat cortex and cerebellum

Chang, P.; Soliman, A.; Li, D., 2001:
Levels of O6-methylguanine and O6-methylguanine methyl transferase in colorectal tumors

Skaug, M.A., 2003:
Levels of Ochratoxin A and IGG against conidia from Penicillium verrucosum in blood samples from healthy farm workers and blood donors

Paumgartten, F.J.R.; Cruz, C.M.; Chahoud, I.; Palavinskas, R.; Mathar, W., 2000:
Levels of PCDD/Fs, PCBs and organochlorine pesticide residues in a pooled sample of mothers milk from Rio de Janeiro, Brazil

Wang, R.Y.; Needham, L.L., 2003:
Levels of Polychlorinated dibenzo-p-dioxins , Polychlorinated dibenzofurans , and Polychlorinated biphenyls in human milk at two US locations

Andersen, N.; Poulsen, S.; Heickendorff, L.; Knudsen, S.; Mogensen, C., 2003:
Levels of Pro-BNP-NT in relation to diastolic function and left ventricular geometry in normoalbuminuric patients with type 2 diabetes

Togawa, A.; Yamamoto, T.; Suzuki, H.; Fukasawa, H.; Fujigaki, Y.; Hishida, A., 2001 :
Levels of Smad 2, 3, 4 and 7 in glomeruli from rats with anti-thymocyte serum nephritis

Dreden, P.V.n; Auvrignon, A.; Fontaine, S.; Leverger, G.; Deschamps, A.; Favier, R., 2002:
Levels of TFPI in Newborns and Infants with Leukaemia

Kawinski, E.; Kumar, B.N.; Huben, R.; Mahoney, M.C.; Phadke, S.; Ambrus, J.L.; Nair, M.P.N.; Schwartz, S.A.; Cherrin, C.; Chadha, K.C., 2003:
Levels of VEGF, IL-8, and TGF-b in patients with prostate cancer and in normal individuals

Sonnet, E.; Gibassier, J.; Derrien, C.; Massart, C.; Allannic, H.; Maugendre, D., 1999:
Levels of adhesion molecules in new onset type 1 diabetic patients

Sanicanin, Z.; Lolic, B.; Uletilovic, S., 2001:
Levels of alpha-1-proteinase inhibitor and total immunoglobulin E in the serum of children passive smokers

Elhassan, Y.M.; Tasca, R.J.; Westhusin, M.E., 1999:
Levels of amino acids in bovine oviductal and uterine fluids in comparison to levels available in a culture medium supplemented with commercial stocks

Harris, L.R.; Beykirch, K.; Fetter, M., 2003:
Levels of analysis of the vestibulo-ocular reflex A postmodern approach

Niven, P.C.; Madjor, D.; Samson, A.; Lee, S.R.; Green, G.A.; Gwo, J.R.; Fong,, 1999:
Levels of antibodies to HCV structural antigens correlate with serum HCV RNA levels in chronic hepatitis C patients undergoing interferon therapy

Galarreta, D.J.; Corrales, R.M.; Herreras, J.M.; Gonzalez, M.J.; Arranz, I.; Saez, V.; Mayo, A.; Cisneros, A.B.; Calonge, M.; Chaves, F.J., 2003:
Levels of antioxidant enzyme genes in conjunctival impression cytology specimens from hydrogel contact lenses wearers

Koc, M.; Taysi, S., 2003:
Levels of antioxidant proteins in serum of patients with cancer during radiotherapy

Gyorffy, E.; Gyori, Z.; Soltesz, I.; Kostic, S.; Csekeo, A.; Minarovits, J.; Schoket, B., 2002:
Levels of aromatic DNA adducts in tumorous and normal tissues from lung cancer patients

Gutierrez Bustillo, M.; Saenz Lain, C., 2000:
Levels of atmospheric pollen of Olea europaea L in Madrid and Aranjuez between 1994 and 1997

Thomas, M.D.; Kalra, P.R.; Jones, A.; Wright, M.; Struthers, A.D.; More, R.S., 2001:
Levels of atrial natriuretic peptide predict short term success of DC cardioversion for persistent atrial fibrillation

Ioannidis, I.; Komitopoulos, N.; Tsaglis, H.; Giakoumaki, A.; Amantou, A.; Sotiropoulou, G.; Varsamis, E.; Katsilambros, N., 1999:
Levels of autoantibodies against oxidized LDL in diabetic subjects are higher when macroangiopathy is present

Lahey, E.C.; Van Den Waardenburg, M.; Blaauwgeers, H.G.T.; D.V.nte, J.; Kessels, A.G.H.; Liem, A.T.A.; Steinbusch, H.; Hendrikse, F., 2001:
Levels of basic fibroblast growth factor , gluatamate synthetase and interleukin-6 in subretinal fluid from patients with retinal detachment

Bairey, O.; Zimra, Y.; Rabizadeh, E.; Shaklai, M., 1999:
Levels of basic fibroblast growth factor in sera of patients with lymphoproliferative diseases

Holman, R.R.; Kahn, S.E.; Heise, M.A.; Porter, L.E.; Freed, M.I.; The Adopt Study Group, 2003:
Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study

Watanabe, Y.; Kimura, S.; Ban Nai, T.; Sahoo, S.K.mar; Kofuji, H.; Yonehara, H., 2000:
Levels of beta-ray emitters in plant samples collected around the uranium conversion facility after the criticality accident in Tokai-mura

Essalam, M.S.f; Donnard, M.; Trimoreau, F.; Allegraud, A.; Autofage, F.; Turlure, P.; Bordessoule, D.; Feuillard, J., 2003:
Levels of blood circulating CD34+ progenitors are correlated with endogenous erythroid colony formation from bone marrow mononuclear cells

Kingdom, Frederick A.A., 2003:
Levels of brightness perception

Vincent Salomon, A.; Zafrani, B.; Nicolas, A.; Couturier, J.; Sastre Garau, X., 2001:
Levels of c-erbB-2 expression similar in primary and secondary breast carcinomas

Wiig, O.; Renzoni, A.; Gjertz, I., 1999:
Levels of cadmium and mercury in the hair of Atlantic walruses from Svalbard, Norway

Adeniyi, A.A.; Idowu, A.B.; Okedeyi, O.O., 2003:
Levels of cadmium, chromium and lead in dumpsites soil, earthworm , housefly and dragon fly

Robillard, S.; Beauchamp, G.; Paillard, G.; Belanger, D., 2002:
Levels of cadmium, lead, mercury and 137caesium in caribou tissues from northern Quebec

Vega,C.M.; Siciliano,S.; Barrocas,P.R.G.; Hacon,S.S.; Campos,R.C.; Jacob,S.doC.; Ott,P.H., 2010:
Levels of cadmium, mercury, and lead in Magellanic penguins stranded on the Brazilian coast

Bueno, M.S.; Cunha, E.A.; Santos, L.E.; Vitti, D.M.S.S., 1999:
Levels of calcium for growing kids Calcium excretion and phosphorus true absorption

Burke, R.T.; Kiessling, L.S., 2000:
Levels of care Primary care residents self-assessment of ability to care for children with chronic health conditions

Russo, V.; Howard, L., 2001:
Levels of carotenoids in fruit from pungent and non-pungent peppers grown in the greenhouse and field

Faderl, S.; Thall, P.F.; Kantarjian, H.M.; Beran, M.; Kornblau, S.; Talpaz, M.; Thomas, D.; Pierce, S.; Harris, D.; Van, Q.; Estrov, Z., 1999:
Levels of caspase 2 and caspase 3 as predictors for complete remission and survival in adults with acute lymphoblastic leukemia

Kerokoski, P.; Puolivali, J.; Roschier, M.; Suuronen, T.; Salminen, A.; Soininen, H.; Pirttila, T., 2000:
Levels of cdk5 and p35 are reduced in neuronal apoptosis and in APP+PS-1 transgenic mice

Feliu, M.S.; Alvarez, R.; Lopez, C.M.; Ramos, O.; Slobodianik, N.H., 2004:
Levels of ceruloplasmine and serum copper in pediatric critical patients Preliminary study

Eish, M.Y.Z.A.oul; Wells, M.J.M.; Stearman, G.K.m; Ensor, D.D.; Hindi, M.M., 2000:
Levels of cesium-137 in relation to land use patterns

Cranmer, M.F.; Louie, S.C.; Cranmer, K.S.; Cranmer, J.M., 1999:
Levels of chlorinated hydrocarbon pesticides in the urban population of Arkansas

Polin, M.R.; Costanzo, J.P.; Yi, S.X.; Lee, R.E., 2003:
Levels of cholesterol in blood and plasma membrane in response to environmental stress in the hatchling painted turtle

Edberg, J.C.; Zhou, T.; Aksu, K.; Kimberly, R.P.; Hoffman, G.S.; S.C.air, E.W.; Merkel, P.A.; Spiera, R.; Dellaripa, P.F.; Regan, M.J.; Allen, N.L.; Clark, T.; Stone, J.H., 2003:
Levels of circulating B lymphocyte stimulator are elevated in patients with Wegeners granulomatosis

Rossig, L.; Kamper, U.; Fichtlscherer, S.; Zeiher, A.M.; Dimmeler, S., 2002:
Levels of circulating apoptotic endothelial cells reflect disease activity in patients with coronary artery disease

Benboubker, L.; Roingeard, F.; Herault, O.; Delam, M.; Degenne, M.; Desbois, I.; Cartron, G.; Colombat, P.; Binet, C.; Domenech, J., 2001:
Levels of circulating progenitor cells assessed for 24 hours following injection of glycosylated or non-glycosylated G-CSF to determine optimal time of graft harvesting

Sandri, M.T.; Zorzino, L.; Bosari, S.; Colleoni, M.; Goldhirsch, A.; Rocca, A.; Viale, G., 1999:
Levels of circulating vascular endothelial growth factor in monitoring the response to anti-angiogenetic therapy in breast cancer

Callas, P.W.; Long, G.L.; Bovill, E.G.; Rosendaal, F.R., 2000:
Levels of clotting factors, including risk factors for venous thrombosis, cluster as discrete groups

Papanikolaou, A.; Wang, Q.S.; Mulherkar, R.; Rosenberg, D.W., 1999:
Levels of colonic non-pancreatic secretory phospholipase A2 are inversely related to azoxymethane-induced tumor susceptibility in mice

Ivanov, G.I., 2003:
Levels of concentration of pollutants in bottom marine environment of the Shotkman gas field

Watkins, R.; Boulton, R.B., 1999:
Levels of copigmentation cofactors in grape skins and wines

Arellano, J.M.; Ortiz, J.B.; D.S.lva, D.C.peta; D.C.nales, M.L.G.nzalez; Sarasquete, C.; Blasco, J., 1999:
Levels of copper, zinc, manganese and iron in two fish species from salt marshes of Cadiz Bay

Schmidt, F.; Hoffmann, J.H.; Donnelly, D., 1999:
Levels of damage caused by Melanterius servulus Pascoe , a seed-feeding weevil introduced into South Africa for biological control of Paraserianates lophantha

Goldstein, N.S., 2002:
Levels of decreased E-cadherin membrane expression for a dyshesive growth pattern and lobular carcinoma-type systemic metastases are different

Khalil, S.A.H.; A.S.areef, A.H., 2000:
Levels of degradation products during storage of rifampicin dosage forms

Josipovic, B., 1999:
Levels of dehydroepiandrosterone sulfate in female patients with early stage of rheumatoid arthritis

Sennvik, K.; Wahlund, L.O.; Winblad, B.; Fastbom, J.; Benedikz, E., 1999:
Levels of differentially cleaved beta-amyloid protein precursor in the cerebrospinal fluid of Alzheimer patients and healthy controls

Koh, P.O.; Lezcano, N.; Bergson, C.; Goldman Rakic, P.S.; Koh, P.O.; Lidow, M.S., 2001:
Levels of dopamine receptor associated proteins, filamin and calcyon, in the prefrontal cortex of schizophrenic and depressive patients

Bradshaw, H.B.; Krey, J.F.; Walker, M., 2003:
Levels of endocannabinoids and related lipid mediators in the female rat reproductive tract change as a function of estrous cycle

Kitakawa, A.Y.; Hamasaki, R.M.; Mercier, H., 2003:
Levels of endogenous free amino acids during induction phase of shoot organogenesis in leaves of pineapple cultured in vitro

Bilodeau, J.F.ancois; Sirard, M.A.dre, 2001:
Levels of enzymatic antioxidant defenses are modulated in bovine oviductal fluid during the estrous cycle

Valik, D.; Nekulova, M.; Vondracek, V.; Jandakova, E.; Petrakova, K., 2002:
Levels of estrogen receptor in breast cancer tissue can be significantly underestimated in specimens taken by core needle biopsy

Meduri, G.U., 1999:
Levels of evidence for the pharmacologic effectiveness of prolonged methylprednisolone treatment in unresolving ARDS

Yoshinaga Itano, Christine, 2004:
Levels of evidence universal newborn hearing screening and early hearing detection and intervention systems

Lange, Carlos E., 2003:
Levels of experimental and natural sporulation of Nosema locustae in grasshopper and locust species of Argentina

Davies, G.; Cunnick, G.H.; Mansel, R.E.; Mason, M.D.; Jiang, W.G., 2002:
Levels of expression of tumor endothelial markers and their correlation with prognosis in patients with breast cancer

Ciftci,H.; Ozkaya,A.; Cevrimli,B.S.; Bakoglu,A., 2010:
Levels of fat-soluble vitamins in some foods

Owens, D.J.; Kneebone, J.W.; Duncan, B.D., 1999:
Levels of fibroblast growth factor Basic and vascular endothelial growth factor in pediatric patients with cyanotic heart disease

Rashev, P.; Kopchaliiska, D.; Georgieva, R., 2001:
Levels of fibronectin in fetal fluids and blood plasma during pregnancy of pigs

Abadi, R.V.; Clement, R.; Gowen, E., 2003:
Levels of fixation

Liang, X.; Shen, D.; Garfield, S.; Gottesman, M.M., 2002:
Levels of gamma-catenin are decreased in cisplatin-resistant cells

Schneider, K.A.; Chittenden, A.B.; Digianni, L.M.; Patenaude, A.F.; Gelman, R.; Garber, J.E., 2001:
Levels of genetics knowledge and distress A comparison of cancer survivors and unaffected women in a BRCA1/2 testing program

Knee, A.M.; Krisher, R.L., 2000:
Levels of glycolytic activity in in vitro matured bovine oocytes are predictive of cleavage potential

Trifonov, I.R.; Katrukha, A.H.; Yavelov, I.S.; Averkov, O.V.; Kuznetsov, B.V.; Gratsiansky, N.A., 2000:
Levels of heart fatty acid binding protein and cardiac troponin I early in the course of acute myocardial infarction in patients receiving thrombolytic therapy

Paz Gonzalez, A.; Taboada Castro, T.; Taboada Castro, M., 2000:
Levels of heavy metals in agricultural soils of Northwest Spain

Zhou, Y.; Franck, J.; Spangler, R.; Maggos, C.E.; Ho, A.; Kreek, M.J., 2000:
Levels of hypothalamic POMC and anterior pituitary CRF1 receptor mRNA are reduced after acute binge alcohol and return to normal levels after chronic daily alcohol administration

Lees, N.P.ter; Hall, N.; Harrison, K.L.; Margison, G.P.; Povey, A.C., 2000:
Levels of immunoreactive O6-alkylguanine DNA-alkyltransferase in normal colorectal mucosa associated with adenomatous polyps and matched controls

Varga, L.; Kiss, K.; Fust, G.; Nagy, K., 2000:
Levels of in vivo generated complement activation products and C1 inhibitor in a C1 inh concentrate-treated patient with capillary leak syndrome following bone marrow transplantation

Vickerman, D.; Michels, A.; Burrowes, P.A., 1999:
Levels of infection of migrating monarch butterflies, Danaus plexippus by the parasite Ophryocystis elektroscirrha , and evidence of a new mode of spore transmission between adults

Fujimoto, T.; Uramoto, H.; Shiiki, H.; Nakamura, S.; Iwano, M., 2001:
Levels of interleukin 18 in the sera and urine of patients with IgA nephropathy

Uramoto, H.; Fujimoto, T.; Maekawa, K.; Shiiki, H.; Okamura, H.; Nakamura, S.; Dohi, K., 2000 :
Levels of interleukin 18 in the sera of patients with lupus nephritis

Radica, D.; Mitrovic, M.; Rakic, R.; Antic, A., 1999:
Levels of intracellular magnesium in preterm labor

Blomberg, B.; Sherwood, E.; Kamm, K.; Young, A.; Ladha, A.; Perez, M.; Lonberg, N.; Karasuyama, H.; Riley, R., 1999:
Levels of lambda 5 may regulate pre-B lymphocyte development in young as well as aged mice

Prabu,P.C., 2010:
Levels of lead in urban soils from Addis Ababa and Nazerath cities of Ethiopia

Crespo, J.; Amado, J.A.tonio; Garcia Unzeta, M.T.resa; Almohalla, C.; Garcia Pajares, F.; Castro, B.; Pons Romero, F., 1999:
Levels of leptin in hepatitis C and its relationship with hepatic fibrosis

Basu, S.; Hayashi, M.; Ritsuko, N.; Kobayashi, K.; Takeda, S.; Ishihara, O., 2002:
Levels of lipid peroxidation products and anti-oxidants in preclampsia and normal pregnancy

Little, R.E.; Gladen, B.C., 1999:
Levels of lipid peroxides in uncomplicated pregnancy: a review of the literature

Danilchik, V.S.; Spivak, L.V.; Zubovskaya, Y.T.; Kolb, V.G.; Kostin, G.M.; Korosteleva, L.B.; Yurago, T.M., 2001:
Levels of lipids peroxidation and antioxidant protection in newborns and their mothers living in radionuclide contaminated regions of Republic of Belarus

Everett, S.M.; Neville, P.; Singh, R.; Leuratti, C.; White, K.; Schorah, C.; Forman, D.; Shuker, D.; Axon, A., 2000:
Levels of malondialdehyde-DNA adducts in gastric mucosa are unaffected by Helicobacter pylori infection

Piro, M.; Liuzzo, G.; Angiolillo, D.J.seph; Rizzello, V.; Colizzi, C.; Raimondi, F.; Ginnetti, F.; Biasucci, L.M.rzio, 2001 :
Levels of mannan binding lectin, an innate immune system plasmaprotein, are elevated in patients with ischemic heart disease and correlate with C-Reactive protein levels

Chen, C.; Isabelle, L.M.; Pickworth, W.B.; Pankow, J.F., 2010:
Levels of mint and wintergreen flavorants: smokeless tobacco products vs. confectionery products

Anstis, Stuart, 2003:
Levels of motion perception

Beloglazov, V.A.; Gordienko, A.I.; Bakova, A.A.; Znamenskaya, L.N.; Rozovenko, A.V.; D.B.ske, L.M., 2003:
Levels of natural antibodies to endotoxin in bronchial asthma patients undergoing allergen specific immunotherapy

Beloglazov, V.A.; Gordienko, A.I.; Bakova, A.A.; Babanin, A.A.; Dubuske, L.M., 2002:
Levels of natural antibodies to endotoxin in healthy individuals in Crimea

Stone, T.W.; Forrest, C.M.; Kennedy, A.; Darlington, L.G.; Gould, S.R., 2002:
Levels of neuroactive purines, kynurenines and lipid peroxidation products in patients with inflammatory bowel disease

Boulanger, L.M.; Colaco, N.A.; Shatz, C.J., 2003:
Levels of neuronal class I MHC determine the threshold for bidirectional synaptic plasticity

Navarro-Gonzálvez, J.A.; Arenas, J.; Díez Lobato, R.; Gómez, P.; Rodríguez-Arias, C.A., 2000:
Levels of nitric oxide are markedly increased in cerebrospinal fluid from patients with severe head injury

Gallai, B.; Mazzotta, G.; Coppola, F.; Floridi, F.; Sarchielli, P., 2003:
Levels of nitrites and sensory neuropeptides in salivary secretions of young migraine patients during attacks

Shishehbor, M.H.; Aviles, R.J.; Brennan, M.L.ise; Fu, X.; Penn, M.S.; Sprecher, D.L.; Gokce, N.; Keaney, J.F.J.; Vita, J.A.; Hazen, S.L., 2003:
Levels of nitrotyrosine, an inflammatory marker generated by nitric oxide derived oxidants, is associated with risk of coronary artery disease

Vetter, W.; Weichbrodt, M.; Scholz, E.; Luckas, B.; Oelschlaeger, H., 1999:
Levels of organochlorines in blubber of South African fur seals from Cape Cross/Namibia

Seljeflot, I.; Aase, O.; Eid, H.; Lyberg, T.; Arnesen, H., 2002:
Levels of oxidative stress are associated with C-reactive protein levels in patients with stable and unstable angina

Mertens, A.; Muls, E.; Vansant, G.; Collen, D.; Holvoet, P., 2000:
Levels of oxidized low density lipoproteins are increased in obese patients

Djedjibegovic,J.; Marjanovic,A.; Sober,M.; Skrbo,A.; Sinanovic,K.; Larssen,T.; Grung,M.; Fjeld,E.; Rognerud,S., 2010:
Levels of persistent organic pollutants in the Neretva River determined by deployment of semipermeable membrane devices

Ruscetti, F.; Cao, Z.; Flanders, K.; Bertolette, D.; Wurthner, J.; Parks, W.T.; Letterio, J.J.; Roberts, A.B., 2002:
Levels of phospho-Smad2/3 are regulators of the commitment to monocytic and granulocytic differentiation of HL-60 cells by TGF-beta, vitamin D3 and retinoic acid

Sterin, M.; Cohen, J.S.; Mardor, Y.; Berman, E.; Ringel, I., 2000:
Levels of phospholipid metabolites in breast cancer cells treated with anti-mitotic drugs A 31P MRS study

Hodt, C.; Hausken, V.; Klasson Heggebo, L.; Fredriksen, P.M., 2003:
Levels of physical activity in 9- to 12-year old children in Norway Do they fulfill the recommendations?

Nilsson, A.; Ekelund, U.; Yngve, A.; Sjostrom, M., 2002:
Levels of physical activity in children and adolescents in comparison with existing recommendations for health

Grypioti, A.D.; Papadimas, G.K.; Fragopoulou, E.; Basagiannis, A.C.; Demopoulos, C.A.; Papadopoulou Daifoti, Z.; Mykoniatis, M.G., 2004:
Levels of platelet-activating factor during liver regeneration after paracetamol-induced liver injury

Yatoh, S.; Mizutani, M.; Kawakami, Y.; Okuda, Y.; Kozawa, T.; Matsuo, K.; Suzuki, H.; Yamashita, K., 1999:
Levels of platelet-derived growth factor and vascular endothelial growth factor are elevated in vitreous fluids from patients with proliferative diabetic retinopathy

Corbella Tena, R.; Garcia Montelongo, F., 1999:
Levels of polychlorinated biphenyls in Patella piperata from the coast of Fuerteventura

Myers, S.R.; Cunningham, C.; Wright, T.; Weeks, J., 2003:
Levels of polycyclic aromatic hydrocarbons in amniotic fluid samples from smokers and nonsmokers

Mohamed, M.A.; Dean, C.; Cunningham Rundles, S.; Nesin, M., 2002:
Levels of pro-inflammatory cytokines produced in vitro are pathogen-dependent

Ross, Helen E., 2003:
Levels of processing in the size-distance paradox

Panagopoulos, G.; Schianodicola, J., 1999:
Levels of professional satisfaction among academic and non-academic anesthesiologists

Taal, M.W.; Rennke, H.G.; Troy, J.L.; Gurnani, A.; Brenner, B.M.; Mackenzie, H.S., 1999:
Levels of proinflammatory cytokine gene expression predict the progression of renal injury in 5/6 nephrectomized rats treated with inhibitors of the renin angiotensin system

Foglesong, P.D.; D'andrea, M.R., 1999:
Levels of protein and mRNA of DNA topoisomerase IIalpha in human tumors

Prathalingam, N.S.; Scaife, J.R.; Heasman, L.; Parker, J.R.; Chapple, D.G.; Lomax, M.A., 2001:
Levels of protein intake in young restricted steers do not affect myofibrillar protein degradation

Yen, H.C.uan; Chang,; Yang, Y.Y.; Majima, H.; Lee, C.P.i, 2003:
Levels of reactive oxygen species and primary antioxidant enzymes in WI38 versus transformed WI38 cells treated with bleomycin

Marelli, D.C.; Arnold, W.S.; Bray, C., 1999:
Levels of recruitment and adult abundance in a collapsed population of bay scallops in Florida

Ratner, S.; Piechocki, M.P.; Lerman, S.P., 1999:
Levels of regulation of lymphocyte appendage formation and polarity

Pomarico, L.; de Souza, I.Pomarico.Ribeiro.; Castro, Góújo.; Teles, R.Palmier.; Luiz, R.Raggio.; Maia, L.Cople., 2010:
Levels of salivary IgA antibodies to Candida spp. in HIV-infected adult patients: a systematic review

Werner, G.T., 1999:
Levels of selenium in the skin of patients with chronic lymphedema

Hamer, P.J.; Burrell, M.; Morris, L.D.; Carney, W.P., 2002:
Levels of serum EGFr in cancer patients

Zozulinska, D.; Sobieska, M.; Wiktorowicz, K.; Wierusz Wysocka, B., 1999:
Levels of serum cell adhesion molecules in Type I diabetic patients with microangiopathy

Yan Guan Ming; Liu; Yang Hong Zhong, 2000:
Levels of serum sTNFR in patients with lung cancer

Dolara, P.; Caderni, G.; Palli, D.; Russo, A.; Morozzi, G.; Cresci, A., 2001:
Levels of short chain fatty acids and bile acids in fecal water and colon mucosa proliferation in humans

Houghton-Triviño, N.; Salgado, D.M.; Rodríguez, J.A.; Bosch, I.; Castellanos, J.E., 2010:
Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation

Blankenberg, S.; Rupprecht, H.J.; Bickel, C.; Schlitt, A.; Lotz, J.; Rippin, G.; Meyer, J., 2000:
Levels of soluble vascular cell adhesion molecule and soluble intracellular adhesion molecule predict future cardiovascular events in patients with documented coronary artery disease

Booij, K.; Zegers, B.N.; Boon, J.P., 2002:
Levels of some polybrominated diphenyl ether flame retardants along the Dutch coast as derived from their accumulation in SPMDs and blue mussels

Rychlik, I.; Tesar, V.; Jirsa, M.; Pacltova, M.; Dudkova, L., 1999:
Levels of some urinary eicosanoids and serum interleukins during fish oil treatment in IgAN

Agrawal, S.M.; Omeljaniuk, R.J., 2000:
Levels of specifically bound ketanserin compared with levels of serotonin in the brain regions of juvenile and sexually recrudescing female rainbow trout, Oncorhynchus mykiss

Slavov, M., 2003:
Levels of sperm - antibodies in andrological patients with urogenital infections and testicular disorders using the direct sperm - MAR test and the direct Immunobead test

Philp, L.; Holloman, E.; Field, M.J.; Williams, R.G., 1999:
Levels of spinal alpha2delta protein and mRNA in a rat model of neuropathic pain

Fromme, H.; Otto, T.; Pilz, K.; Neugebauer, F., 1999:
Levels of synthetic musks; bromocyclene and PCBs in eel and PCBs in sediment samples from some waters of Berlin / Germany

Veng, L.M.; Nixon, K.M.; Mesches, M.H.; Browning, M.D., 2001:
Levels of the L-type calcium channel subunit alpha1D are reduced in aged rat hippocampus

Sturk, L.; Hall, J.E.; Holman, J.A.; Kalvass, C.; Tidwell, R.R., 2003:
Levels of the anti-trypanosomal prodrug 2,5-bis furan-O-bis-amidoxime and its metabolites within murine brain tissue

Bulgakova, V.A.; Sentsova, T.B., 2001:
Levels of the interleukin-2 and interleukin-6 in children with atopic dermatitis

Batpenova, Gulnara, 2003:
Levels of the ionized calcium and 25-oxyergolcalcepherol in children with exudative psoriasis

Washabaugh, C.H.; Ontell, M.P.; Tajbakhsh, S.; Kant, J.A.; Ontell, M., 2002:
Levels of the three remaining myogenic regulatory factors in muscles of myf-5 null mice

Madhok, A.B.; Chandrasekran, A.; Parnell, V.A.; Chowdhury, D.; Pahwa, S., 2003:
Levels of thymic recent emigrant cells decreases in children undergoing thymectomy during cardiac surgery

Zaitseva, T.; Schears, G.; Schultz, S.; Creed, J.; Wilson, D.F.; Pastuszko, A., 2003:
Levels of total and phosphorylated cyclic AMP response binding protein in striatum following cardiopulmonary bypass

Marquez, M.; Vodopivez, C.; Casaux, R.; Curtosi, A., 1999:
Levels of total mercury in Antarctic organisms from King George Island, South Shetland Islands, Antarctica

Charjan, P.; Mangle, N.S.; Kalorey, D.R.; Kuralkar, S.V., 2003:
Levels of total whey protein and immunoglobulin in udder health status of cow

Gouteux, B.; Lebeuf, M.; Gagne, J.P., 2000:
Levels of toxaphene congeners in a marine food web from the St Lawrence Estuary, Canada

Dobrikova, E.Y.; Cabello, F.C., 2000:
Levels of transcription and promoter identification of Borrelia burgdorferi bmp genes

Tsianos, E.V.; Christodoulou, D.K.; Katsanos, K.H.; Eleftheriou, A.; Gartzonika, K.; Mavridis, A., 2000:
Levels of transferrin, haptoglobulins and factor B of properdine in patients with inflammatory bowel disease

Dimitrakopoulos, C.; Gouzoumas, N.; Karvounis, H.; Styliadis, I.; Nouskas, I.; Karamouzis, M.; Parharidis, G.; Louridas, G., 2001:
Levels of troponin I, ANP and c-GMP as indices of improvement of left ventricular function after DDD pacing for complete AV-block

Odeh, M.; Sabo, E.; Srugo, I.; Oliven, A., 2002:
Levels of tumor necrosis factor-alpha correlate with polymorphonuclear leukocyte count in complicated parapneumonic effusion

Bradley, L.A.; Palomaki, G.E.; Knight, G.J.; Haddow, J.E.; Opitz, J.M.; Irons, M.; Kelley, R.I.; Tint, G.S.ephen, 1999:
Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz syndrome fetuses

Milanese, G.; Muzzonigro, G.; Galosi, A.B.; Vivani, C.; Sier, C.F.M.; Blasi, F.; Fazioli, F., 2000:
Levels of urokinase-type plasminogen activator receptor in serum and urine of bladder cancer patients Preliminary results

Blann, A.D.; Belgore, F.M.; Lip, P.L.; Lip, G.Y.H., 2000:
Levels of vascular endothelial growth factor and its receptor Flt-1 in type 2 diabetes with or without atherosclerosis

Lee, S.S.ok; Joo,; Kim, W.U.; Min, J.K.; Hong, Y.S.k; Lee, S.H.on; Park,; Cho, C.S.o; Kim, H.Y.un, 1999:
Levels of vascular endothelial growth factor in serum and synovial fluid of patients with rheumatoid arthritis

Onuoha, G.N.; Alpar, E.K., 2001:
Levels of vasodilators and vasoconstrictor peptides in early human burns

Sester, M.; Sester, U.; Gaertner, B.; Heine, G.; Girndt, M.; Mueller Lantzsch, N.; Meyerhans, A.; Koehler, H., 2000:
Levels of virus-specific CD4 T-cells correlate with cyto-megalovirus control and predict virus-induced disease following renal transplantation

Parker, J.; Hashmi, O.; Dutton, D.; Mavrodaris, A.; Stranges, S.; Kandala, N-Bakwin.; Clarke, A.; Franco, O.H., 2010:
Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis

Martin, A.; Bermudez, O.I.; Youdim, K.; Joseph, J.A.; Tucker, K.L., 2000:
Levels of vitamin E, ICAM-1 and arachidonic acid in an elderly Hispanic and non-Hispanic population Implications to the well-being of elders

Cardigan, R.; Allford, S.; Williamson, L., 2002:
Levels of von Willebrand factor-cleaving protease are normal in methylene blue-treated fresh-frozen plasma

Hirsch, R.; Ostchega, Y.; Guralnik, J., 1999:
Levels of walking speed and lower extremity joint involvement in older US adults

Ciric, D.; Ciric, M.; Jovic, M.; Djordjevic, R.; Boskovic, D.; Stankovic, S., 1999:
Levels prolactin and TSH to haloperidol in schizophrenic patients before and after treatment

Caggiano,R.; Macchiato,M.; Trippetta,S., 2010:
Levels, chemical composition and sources of fine aerosol particles in an area of the Mediterranean basin

Imai, K.; Mori, Y., 1999:
Levels, inheritance and stability of resistance to Bacillus thuringiensis formulation in a field population of the diamondback moth, Plutella xylostella from Thailand

Forkey, J.N.; Keleti, D.; Shaw, M.A.exander; Goldman, Y.E., 2004:
Lever arm angles in single-headed proteolytic fragments of myosin V

Reno, Waldix Teixeira, 2001:
Lever retractor for surgical flaps with handle

Baron, R.J.; Arndt, R.; Blinow, I., 2001:
Lever-style drain assembly for urine collection container

Mullaney, B.P.; Williams, K.; Pytela, R.; Pallavicini, M., 2002:
Leveraging immune diversity and mass spectrometry by antibody proteomics

Pegg, S.C.H.; Babbitt, P., 2003:
Leveraging information from enzyme superfamily studies

Nash, Elby, 2003:
Leveraging knowledge assets to accelerate discovery An introduction

Skingle, Malcolm, 2001:
Leveraging technology through academic-industrial collaboration

Ardid, D.; Lamberty, Y.; Alloui, A.; Coudore Civiale, M.A.; Eschalier, A., 2001:
Levetiracetam , a new antiepileptic drug, is effective in neuropathic but not acute pain models in rats

Klitgaard, H.; Matagne, A.; Grimee, R.; Goemaere, J.; Margineanu, D., 1999:
Levetiracetam /UCB L059 protects against pilocarpine-induced seizures in rats Characterization of electrophysiological and biochemical effects and identification of brain areas involved

Lippmann, S.M.; Montouris, G.D.; Rosenfeld, W.E.; Schaefer, P.A., 2002:
Levetiracetam A helpful new drug

Dooley, M.; Plosker, G.L., 2000:
Levetiracetam. A review of its adjunctive use in the management of partial onset seizures

Isik, U.; Greenwod, R.S.; Tennison, M.B.; Boyce, L.H.; D'cruz, O'neill F., 2001:
Levetiracetam A single center experience

Nohria, V.; Leppik, I.E.; Verdru, P.; Debrabandere, L., 1999:
Levetiracetam Evaluation of success rate in secondarily generalized seizures in addition to activity in partial seizures

Van Rijckevorsel, Kenou, 2000:
Levetiracetam Evaluation of the number needed to treat

Niespodziany, I.; Klitgaard, H.; Margineanu,, 2000:
Levetiracetam Modulation of high voltage-activated Ca2+ current in Ca1 pyramidal neurons of rat hippocampal slices

Hans, G.; Nguyen, L.; Rocher, V.; Belachew, S.; Moonen, G.; Matagne, A.; Klitgaard, H., 2000:
Levetiracetam No relevant effect on ionotropic excitatory glutamate receptors

Rigo, J.M.; Nguyen, L.; Belachew, S.; Mulgrange, B.; Leprince, P.; Moonen, G.; Selak, I.; Matagne, A.; Klitgaard, H., 2000:
Levetiracetam Novel modulation of ionotropic inhibitory receptors

Koukkari, M.W.; Guarino, T.J., 2002:
Levetiracetam Retrospective experience in pediatric patients with multiple seizure types

Leppik, I.E.; Gauer, L., 2000:
Levetiracetam Serious adverse experiences and SUDEP

Kramer, G.; Hosli, I.; Glanzmann, R.; Holzgreve, W., 2002:
Levetiracetam accumulation in human breast milk

Bastlund, J.F.; Watson, W.P.; Sanchez, C., 2002:
Levetiracetam and phenytoin show greater efficacy at reducing nicotine-kindled seizures than PTZ-kindled seizures in mice

Mushtaq, R.; Wannamaker, B.B., 2002:
Levetiracetam blood levels have utility in clinical management of epilepsy

Imperiale, D.; Bortolotto, S.; Cucatto, A.; Schiffer, P.; Cassano, D.; Buffa, C., 2003:
Levetiracetam control of myoclonus in a patient with Creutzfeldt-Jakob disease

Perucca, E.; Gidal, B.E.; Ledent, E.; Baltes, E., 2000:
Levetiracetam does not interact with other antiepileptic drugs

Scuvee Moreau, J.; Thomas, E.; Seutin, V., 2002:
Levetiracetam does not modulate SK channel activity in CA1 hippocampus pyramidal cells in vitro

Baltez, E.; Coupez, R., 2000:
Levetiracetam dose adjustment for patients on hemodialysis

Hovinga, C.; Morris, H.; Holland, K.; Foldvary, N.; Kotagal, P.; Wyllie, E., 2001:
Levetiracetam efficacy in adults and children

Klitgaard, H.; Matagne, A., 2002:
Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in amygdala-kindled rats

Matagne, A.C.; Baltes, E.; Coupez, R.; Patsalos, P.N.; Klitgaard, H.V. , 2001:
Levetiracetam enhances markedly the seizure suppression of other antiepileptic drugs in audiogenic susceptible mice

Crawford, P.; Danniau, A.; Waegemans, T., 1999:
Levetiracetam for the treatment of refractory epilepsy Tolerability and efficacy as add-on treatment without up-titration period

Niespodziany, I.; Klitgaard, H.; Margineanu, D.G., 2000:
Levetiracetam had no effect on the low-voltage-activated Ca2+ current in rat CA1 hippocampal neurons

Litzinger, M.J.; Hanny, A., 2002:
Levetiracetam has a positive response in refractory pediatric partial seizure patients with visual triggers

Dedeurwaerdere, S.M.; Claeys, P.; Raedt, R.A.; D.S.edt, T.; Vonck, K.; Grisar, T.; Boon, P.A.J.M., 2003:
Levetiracetam has antiepileptogenic properties in GAERS

Dedeurwaedere, S.; Claeys, P.; D.S.edt, T.; Raedt, R.; Vonck, K.; Grisar, T.; Boon, P., 2004:
Levetiracetam has antiepileptogenic properties in genetic absence epilepsy rats from Strasbourg

Mandler, R.N.; Choi, J.M.; Kingery, E.R.; Barber, A.M., 2003:
Levetiracetam improves cerebellar tremor in multiple sclerosis

Rüegg, S.J.; Steck, A.J.; Fuhr, P., 2004:
Levetiracetam improves paroxysmal symptoms in a patient with stiff-person syndrome

Papavasiliou, A.; Korkoli, E.; Paraskevoulakos, E.; Kotsalis, C., 2004:
Levetiracetam in childhood treatment-resistant epilepsy

Mordekar, S.R.; Peake, D.; Philip, S.; Gosalakkal, J.; Rittey, C.D.R.; Whitehouse, W.P., 2004:
Levetiracetam in children with intractable epilepsy preliminary results of a clinical audit

Kraemer, G.; Edrich, P., 2001:
Levetiracetam in elderly patients with epilepsy

Wasterlain, C.G.; Mazarati, A.M.; Klitgaard, H.V.; Baldwin, R.A., 2001:
Levetiracetam in experimental status epilepticus

Vigevano, F., 2004:
Levetiracetam in paediatrics

Cramer, J., 2000:
Levetiracetam in partial epilepsy Results of pooled data

Ferrendelli, J.; French, J.; Leppik, I.; Morrell, M.J.; Magnus, L., 2003:
Levetiracetam in patients aged gtoreq65 years A subset of the KeeperTM Trial

Johannessen, S.I.; Helde, G.; Brodtkorb, E., 2004:
Levetiracetam in pregnancy and lactation preliminary observations

Krakow, K.; Otoul, C.; Walker, M.C.; Sander, J.W., 2000:
Levetiracetam in refractory epilepsy Predictors of long-term retention

Kkolou, E.; Papacostas, S., 2004:
Levetiracetam is effective and well-tolerated in patients with intractable epilepsy, A.; Boero, G.; Specchio, N.; Santosabato, M.; D.P.lo, A.; D.A.azio, G.; Specchio, L.M., 2004:
Levetiracetam is effective in juvenile myoclonic epilepsy

Lindholm, Dwight, 2002:
Levetiracetam levels correlating with successful treatment of epilepsy, headaches, cognitive effects, and adverse reactions in pediatric age group

Alsaadi, T.M.; Thieman, C., 2002:
Levetiracetam monotherapy for adults with epilepsy

Arrigo, A.; Raiteri, U.; Ardizzone, G.; Regesta, G.; Ottonello, G.A., 2004:
Levetiracetam monotherapy for the treatment of partial status epilepsy in a patient following a liver transplant

Mintz, M.; Graner, C.A.n; Blumenfeld, S.; Alberts, L., 2002:
Levetiracetam monotherapy in pediatric patients

Resor, S.R.; Resor, L.R., 2002:
Levetiracetam monotherapy in the treatment of convulsive seizures in patients with juvenile myoclonic epilepsy

French, J.A.; Cramer, J.; Edrich, P., 2001:
Levetiracetam overall safety profile

Ghattaura, S.; Ratnaraj, N.; Sander, J.W.; Patsalos, P.N., 2004:
Levetiracetam pharmacokinetics in patients with intractable epilepsy

Barrueto, F.; Williams, K.; Howland, M.A.; Hoffman, R.S.; Nelson, L.S., 2002:
Levetiracetam poisoning induces coma Confirmed by laboratory analysis

Hill, M.P.; Ravenscroft, P.; Bezard, E.; Crossman, A.R.; Brotchie, J.M.; Michel, A.; Grimee, R.; Klitgaard, H., 2003:
Levetiracetam potentiates the anti - dyskinetic action of amantadine in the MPTP - lesioned marmoset model of Parkinsons disease

Bezard, E.; Brotchie, J.M.; Crossman, A.R.; Hill, M.P.; Michel, A.; Grimee, R.; Klitgaard, H.V., 2003:
Levetiracetam reduces L-DOPA-induced choreic dyskinesia in the MPTP-lesioned macaque

Brotchie, J.M.; Bezard, E.; Crossman, A.R.; Hill, M.P.; Michel, A.; Grimee, R.; Klitgaard, H.V., 2003:
Levetiracetam reduces L-DOPA-induced dyskinesia in the MPTP-lesioned marmoset model of parkinsons disease

Angehagen, M.; Margineanu,; Ronnback, L.; Hansson, E.; Klitgaard, H.; Ben Menachem, E., 2002:
Levetiracetam reduces caffeine-induced intracellular calcium transients in cultured rat hippocampal neurons

Gallagher, M.J.; Attarian, H.; Fessler, A.J.mes; Eisenman, L.N.; Altay, E.E.bayat; Dong, J.; Hecimovic, H.; Gilliam, F., 2002:
Levetiracetam reduces interictal spike-wave complexes in patients with idiopathic generalized epilepsy

Coupez, R.; Straetemans, R.; Sehgal, G.; Armel, S.; Lu, Z., 2004:
Levetiracetam relative bioavailability and bioequivalence of 10% oral solution and 750 Mg tablets

Lukyanetz, E.A.; Shkryl, V.M.; Kostyuk, P.G., 2001:
Levetiracetam selectively blocks N-type calcium channels in rat isolated CA1 hippocampal neurons

Werz, M.A.n; Lang, P.; Rienzo, T., 2003:
Levetiracetam therapy for epilepsy Use and tolerability in the elderly

Franz, D.N.; Leonard, J.M.; Tudor, C.A.; Chuck, G.; Egelhoff, J., 2002:
Levetiracetam therapy of epilepsy in tuberous sclerosis

Locatelli, P.; Lapadula, G.; Casari, S.;, I.; Uccelli, C.; Vignolo, L.A., 2004:
Levetiracetam use in patients with HIV infection and retroviral therapy

Martien, Katherine M., 2003:
Levetiracetam utility in autistic children limited by behavioral side effects

Molsa, P.K., 2004:
Levetiracetam versus gabapentin as adjunctive therapy in the treatment of catastrophic epilepsy

Gidal, B.E.; Sheth, R.; Maganti, R.; Magnus, L.; Herbeuval, A.F.ancoise, 2001:
Levetiracetam weight change during placebo-controlled clinical trials

Kimland, E.; Höjeberg, B.; von Euler, M., 2004:
Levetiracetam-induced thrombocytopenia

Mesad, S.M.; Devinsky, O., 2002:
Levetiracetam-related aggression

Goldstein, J.L.; Trevathan, E.; Arnold, S.T.; Dodson,, 2001:
Levetiracitam Exacerbation of epilepsy

Korby, B.; Penovich, P.E.; Gates, J.R.; Dickens, D.L.; Moriaraty, G.L., 2003:
Leviteracetam monotherapy

Rasmini, P.; Besana, D.; Giribone, S., 2004:
Levitracetam as add-on therapy in childhood drug resistant epilepsy

Tillman, T.N.; Thompson, D.L.; Rafool, G.J., 2000:
Levo-monosaccharide in a nucleoside analog for use as an anti-retroviral agent

Foster, R.H.; Markham, A., 2000:
Levobupivacaine: a review of its pharmacology and use as a local anaesthetic

Munir, M.A.; Li, H.; Jaffar, M.; Ghaleb, A.; Zhang,, 2003:
Levobupivacaine Blocks Lumbar Ganglion Compression-Induced Mechanical Hyperalgesia and Allodynia beyond Its Duration of Action

Urbanek, B.; Duma, A.; Kimberger, O.; Marhofer, P.; Kapral, S., 2002:
Levobupivacaine Versus Bupivacaine for 3-in-1 Blocks

Glaser, C.; Marhofer, P.; Zimpfer, G.; Kapral, S.; Schindler, I., 2002:
Levobupivacaine Versus Bupivacaine for Spinal Anesthesia

Ivani, G.; D.N.gri, P.; Grossetti, R.; Vercellino, C.; Gagliardi, F., 2002:
Levobupivacaine Vs Ropivacaine Vs Bupivacaine in Pediatric Caudal Anesthesia

Mather, L.E.; Richards, Mcglashan, 2003:
Levobupivacaine and its use

Bardsley, H.J.dith; Gristwood, R.W.lliam; Richards, Mcglashan, 2002:
Levobupivacaine as an analgesic agent

Gunter, J.B.; Gregg, T.; Varughese, A.M.; Wittkugel, E.P.; Berlin, R.E.; Ness, D.A.; Overbeck, D.E., 1999:
Levobupivacaine for ilioinguinal/iliohypogastric nerve block in children

Bardsley, H.J.dith; Mather, L., 1999:
Levobupivacaine for managing chronic pain

Herroeder, S.; Kurz, K.S.; Durieux, M.E.; Berkelmans, N.S.; Hollmann, M.W., 2002:
Levobupivacaine inhibits neutrophil priming more profoundly than does bupivacaine

Pistone, G.; Marino, A.; Leotta, C.; Dell'Arte, S.; Finocchiaro, G.; Malaguarnera, M., 2003:
Levocarnitine administration in elderly subjects with rapid muscle fatigue: effect on body composition, lipid profile and fatigue

Clutterbuck, E.J.; Laffan, M., 2002:
Levocarnitine supplementation improves red blood cell survival and clinical symptoms in haemodialysis patients

Pellet, C.; Jean Louis, F.; Boland, S.; Dubertret, L.; Michel, L., 2004:
Levocetirizine decreases VCAM-1 expression induced by TNF-alpha in human dermal endothelial cells through down-regulation of NF-kappaB pathway

Thomson, L.; Blaylock, M.G.; Walsh, G.M., 2001:
Levocetirizine inhibits eotaxin-induced eosinophil transendothelial migration through human dermal or lung microvascular endothelial cells

Nakamori, S.; Shimizu, S.; Wada, M., 2002:
Levodione reductase

Harder, S.; Dietz, M.; Leenders, K.; Baas, H., 1999:
Levodopa PK-PD-analysis in relation to F-Dopa-PET in patients with Parkinsons disease

Agid, Y.; Olanow, C.W.; Mizuno, Y., 2002:
Levodopa: why the controversy?

Black, K.J.; Hershey, T.; Akbudak, E.; Snyder, A.Z.; Barch, D.; Carl, J.L.; Conturo, T.E.; Hartlein, J.M.; Koller, J.M.; Perlmutter, J.S., 2003:
Levodopa activation pharmacologic fMRI in Tourettes syndrome

Steiner, I.; Wirguin, I., 2003:
Levodopa addiction in non-parkinsonian patients

Grondin, R.; Zhang, Z.; Gerhardt, G.A.; Gash, D.M., 1999:
Levodopa and GBR-12909 improve fine motor performance in aged rhesus monkeys

Luquin, R.; Del Rio, L.; Saldise, L.; Setuain, J.; Manzi, B., 2001:
Levodopa but not pergolide administration induces apoptosis in the substantia nigra neurons of rats with partial nigrostriatal lesion

Müller, U.; Reuter, M.; Hermann, W.; Gertz, H.J., 2002 :
Levodopa dependency in Parkinson's disease: case report and review

Payoux, P.; Brefel Courbon, C.; Quelven, I.; Thalamas, C.; Galitzky, M.; Chollet, F.; Esquerre, J.P.; Rascol, O., 2003:
Levodopa effect on experimental pain in Parkinson disease A PET activation Study

Rumbach, L.; Bouhaddi, M.; Vuillier, F.; Sablot, D.; Capelle, S.; Chavot, D.; Henriet, M.T.erese; Moulin, T.; Regnard, J., 2001:
Levodopa impairs baroreflex adjustment of circulatory homeostasis in Parkinsons Disease

Kelly, V.E.; Hyngstrom, A.J.; Bastian, A.J., 1999:
Levodopa improves non-cued reaching more than cued reaching in Parkinsons disease

Murer, M.G.; Raisman-Vozari, R.; Gershanik, O., 1999:
Levodopa in Parkinson's disease: neurotoxicity issue laid to rest?

Muller, T.; Woitalla, D.; Fowler, B.; Przuntek, H.; Kuhn, W., 2001:
Levodopa induced altered O-methylation in parkinsonian subjects

Feigin, A.; Mentis, M.J.; Dhawan, V.; Margouleff, C.; Eidelberg, D., 2000:
Levodopa infusion reduces the expression of a Parkinsons disease metabolic brain network An FDG PET study

Gonzalez Hernandez, B.; Silva, I.; Rangel, C.; Floran, L.; Aceves, J.; Floran, B., 2002:
Levodopa via d2 receptors inhibits gaba release in the rat globus pallidus of 6 hydroxydopamine lesioned rats

Metman, L.Verhagen, 2001:
Levodopa-associated dyskinesias Clinical features and treatment strategies

Loeffler, D.A.; Camp, D.M.; Mendiratta, M.; Yagiela, H.; Lewitt, P.A.; Hyland, K., 1999:
Levodopa-induced alterations in regional brain concentrations of norepinephrine, serotonin and their metabolites in 6-OHDA hemilesioned rats

Martel, J.C.; Colpaert, F.C.; Marien, M., 1999:
Levodopa-induced changes in striatal extracellular levels of dopamine and metabolites in nigrostriatal-lesioned rats in vivo Effects of -idazoxan

Togasaki, D.M.; Tan, L.; Protell, P.; Delanney, L.E.; D.M.nte, D.A.; Quik, M.; Langston, J.W., 2000:
Levodopa-induced dyskinesias in unlesioned monkeys

Yasui, K.; Nakaso, K.; Kowa, H.; Takeshima, T.; Nakashima, K., 2003:
Levodopa-induced hyperhomocysteinaemia in Parkinson's disease

Marin, C.; Bove, J.; Jimenez, A.; Bonastre, M.; Molinuevo, J.L.; Tolosa, E., 2000:
Levodopa-induced motor fluctuations are dissociated from striatal c-jun expression in parkinsonian rats

van Laar, T., 2003:
Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management

Fobelo Lozano, M.J.; Miguel Del Corral, M., 1999:
Levodopa/Carbidopa solution in advanced Parkinsons disease patients

Kaseda, S.; Tsujimura, S.; Mitsuda, M.; Osame, M.; Nomoto, M., 2001:
Levodopa/benserazide tablets showed higher bioavailability of levodopa than levodopa/carbidopa tablets

Mahgoub, S.; Hochstein, L.; Kopetz, V.; LaBombardi, V.; Leggiadro, R.; Glatt, A.E., 2003:
Levoflaxin and Streptococcus pneumoniae

Harding, I.; Simpson, I., 2001:
Levofloxacin A cost-effective agent for the treatment of community acquired pneumonia

Croom, K.F.; Goa, K.L., 2003:
Levofloxacin: a review of its use in the treatment of bacterial infections in the United States

Harding, I.; Simpson, I.; O'hare, M., 2001:
Levofloxacin A safe and well tolerated fluoroquinolone

Hurst, M.; Lamb, H.M.; Scott, L.J.; Figgitt, D.P., 2002:
Levofloxacin: an updated review of its use in the treatment of bacterial infections

Simpson, I.; Harding, I., 2001:
Levofloxacin Factors responsible for the low potential for resistance development among isolates of Streptococcus pneumoniae

Simpson, I.N.; Harding, I., 2001:
Levofloxacin Low potential for fluoroquinolone-resistance development among Streptococcus pneumoniae

O'hare, M.; Simpson, I., 2001:
Levofloxacin Review of efficacy and tolerability, relative to beta-lactams+-macrolides, in the treatment of community-acquired pneumonia

Simpson, I.N.; Harding, I., 2001:
Levofloxacin Review of tolerability and safety

Harding, I.; Simpson, I., 2001:
Levofloxacin The criterion AUC/MIC30 provides a robust model for predicting clinical outcome against Streptococcus pneumoniae

Hoban, D.J.; Karlowsky, J.A.; Zhanel, G.G., 1999:
Levofloxacin activity against recent Canadian respiratory tract pathogens

Phung, P.; Tong, T.; Gurevitch, M.; Wong Beringer, A., 2000:
Levofloxacin and cefotaxime, alone versus in combination for the treatment of community-acquired pneumonia in hospitalized patients Impact on medical outcomes

Schaeffer, A.J.; Wu, S.C.en; Tennenberg, A.M.; Zadeikis, N., 2004:
Levofloxacin and ciprofloxacin in the treatment of chronic bacterial prostatitis lower serum prostate specific antigen

Clark, C.L.; Jacobs, M.R.; Appelbaum, P.C., 1999:
Levofloxacin and clarithromycin antipneumococcal activity

Rudnic, E.M.; Isbister, J.D.; Treacy, D.J.J.; Wassink, S.E., 2003:
Levofloxacin antibiotic product, use and formulation thereof

Mitrokhin, S.D., 2003:
Levofloxacin antimicrobial activity

Timmers, G.J.; Simoons Smit, I.M.; Van Winkelhoff, A.J.; Dijstelbloem, Y.; Touw, D.; Vandenbroucke Grauls, C.M.; Huijgens, P.C., 2000:
Levofloxacin as antibacterial prophylaxis in neutropenic patients with hematological malignancies

Chiang, F.Y.; Mudduluru, M.; Alcid, D., 2000:
Levofloxacin associated increase in methicillin-resistant staphylococcus aureus infections

Yakovlev, S.V.; Yakovlev, V.P., 2002:
Levofloxacin at the treatment of respiratory tract infections

Festa, V.; Perri, F.; Boschetto, S.; Giovannone, M.; Tosoni, M.; Andriulli, A.; Barberani, F., 2002:
Levofloxacin based triple therapy as second-line treatment for H pylori infection after failure of standard triple therapy

Oksanen, A.M.; Rautelin, H., 2003:
Levofloxacin combination therapy for clarithromycin and metronidazole resistant Helicobacter pylori strains

Friedlaende, M.H.; Rubin, J.M.; Padilla, E.; Amdahl, L.D., 2000:
Levofloxacin concentration in tears following topical administration of 05% levofloxacin ophthalmic solution in healthy volunteers

Iannini, P.B., 2001:
Levofloxacin delays cardiac repolarization in hospitalized patients

Bellmann, R.; Egger, P.; Pechlaner, C.; Feistritzer, C.; Vogel, W.; Joannidis, M.; Wiedermann, C.J., 2003:
Levofloxacin elimination during albumin dialysis

O'hare, M.; Simpson, I., 2001:
Levofloxacin for the treatment of acute bacterial sinusitis

Harding, I.; O'hare, M., 2001:
Levofloxacin for the treatment of community acquired pneumonia Clinical advantages over other empiric therapies

O'hare, M.; Harding, I., 2001:
Levofloxacin for treatment of acute bacterial exacerbations of chronic bronchitis Advantages over currently available therapies

Felmingham, D.; Harding, I., 2001:
Levofloxacin for treatment of respiratory tract infections Excellent in vitro activity and low prevalence of resistance

O'hare, M.; Harding, I., 2001:
Levofloxacin has low potential for cardiovascular adverse reactions

Kahn, J.B.; Wiesinger, B.A.; Khanna, M., 1999:
Levofloxacin in the management of community-acquired pneumonia due to penicillin- and multiple drug-resistant pneumococci

Kahn, J.B.; Wiesinger, B.A.; Morgan, N., 2000:
Levofloxacin in the treatment of bacteremic pneumococcal pneumonia

Kahn, J.B.; Wiesinger, B.A.; Scott Marshall, J.A.n; Olson, W.H., 2000:
Levofloxacin in the treatment of community-acquired pneumonia due to penicillin-resistant and -susceptible pneumococci and other pathogens

Perry, A.; Rouse, M.S.; Piper, K.E.; Hanssen, A.D.; Steckelberg, J.M.; Patel, R., 2001:
Levofloxacin inhibits fracture healing in a rat model of implant stabilized experimental fractures

Simpson, I.; Jones, N., 2001:
Levofloxacin is at least as safe and effective as ciprofloxacin and lomefloxacin in the treatment of intra-abdominal, urinary tract and skin and soft tissue infections

Kawada, A.; Aragane, Y.; Tezuka, T., 2002:
Levofloxacin is effective for inflammatory acne and achieves high levels in the lesions: an open study

Simpson, I.N.; Harding, I., 2001:
Levofloxacin is not associated with significant hepato-biliary adverse reactions

Yu, Y.L.; Williams, R.R.; Stout, J.E.; Greenberg, R.N.; Kojak, C.M., 2001:
Levofloxacin is safe and effective in the management of community-acquired pneumonia due to Legionella

Shvab, M.; Lobel, S.; Scheuering, S.; Kisch, A.L., 2000:
Levofloxacin misuse in the emergency department An expensive hospital liability

Ibrahim, K.H.; Hovde, L.B.; Brown, G.H.; Rotschafer, J.C., 1999:
Levofloxacin pharmacodynamics vs Streptococcus pneumoniae

Chung, E.; Drusano, G.L.; Nafziger, A.N.; Bertino, J.S.J., 2003:
Levofloxacin pharmacokinetics in patients with community acquired pneumonia and varying severity of illness as assessed by the pneumonia severity index

Lucksiri, A.; Kays, M.B.; Hamburger, R.J.; Mueller, B.A.; Scott, M.K.; Sowinski, K.M., 2001:
Levofloxacin pharmacokinetics in patients with end-stage renal disease

Harr, M.S.; Hutcheson, J.A.; Laurent, A.L.; Graves, A.L.; Van Buskirk, A.L., 2000:
Levofloxacin plasma concentrations following topical administration of 05% levofloxacin ophthalmic solution in healthy adult volunteers

Nomura, H.; Tsutsumi, N.; Terasaka, R., 1999:
Levofloxacin prevented liver abscess and suppurative cholecystitis following transcatheter arterial embolization for hepatocellular carcinoma

Nazir, J.; Urban, C.; Mariano, N.; Burns, J.; Segal Maurer, S.; Rahal, J.J., 2002:
Levofloxacin resistant Haemophilus influenzae in a long term care facility

Anderson, D.M.; Dudas, V., 2003:
Levofloxacin resistant Streptococcus pneumoniae An evaluation of isolates and patients from 2000-2002

Wehbeh, W.; Rojas Diaz, R.; Mariano, N.; Grenner, L.; Segal Maurer, S.; Urban, C.; Rahal, J.J., 2003:
Levofloxacin resistant group B streptococci

O'hare, M.; Harding, I., 2001:
Levofloxacin therapy for community-acquired pneumonia due to atypical and intracellular microorganisms

Davidson, R.J.; D.A.avedo, J.; Bast, D.; Arbique, J.; Bethune, R.; Duncan, C.; Mcgeer, A.; Low, D.E., 2000:
Levofloxacin treatment failure of pneumococcal pneumonia and development of resistance during therapy

Nickel, J.C.rtis; Downey, J.; Clark, J.; The Canadian Prostatitis Research Group, 2003:
Levofloxacin treatment for chronic prostatitis/chronic pelvic pain syndrome in men A randomized placebo controlled multi-center trial

Tsai, C-Chi.; Lay, C-Jang.; Wang, C-Lung.; Ho, Y-Huai.; Wang, L-Shinn.; Chen, L-Kuang., 2010:
Levofloxacin versus tetracycline antibiotics for the treatment of scrub typhus

Kahn, J.B.; Wiesinger, B.A.; Oross, M.P.; Olson, W.H., 2000:
Levofloxacin vs ceftriaxone and erythromycin followed by clarithromycin and amoxicillin/clavulanate in serious community-acquired pneumonia

Kahn, J.B.; Wiesinger, A.; Olson, W.H.; Oross, M.; Reichl, V., 2001:
Levofloxacin vs ceftriaxone sodium and erythromycin in the treatment of patients with community-acquired pneumonia at high risk of mortality

Simpson, I.; Harding, I., 2001:
Levofloxacin, ofloxacin and ciprofloxacin are poor inhibitors of the HERG channel and have little ability to prolong QT interval

Solomon, N.M.; Mokrzycki, M.H., 2000:
Levofloxacin-induced allergic interstitial nephritis

Klugman, K.P., 2000:
Levofloxacin-resistant pneumococcus

Micheletto, C.; Tognella, S.; Pomari, C.; Dal Negro, R., 2002:
Levofloxacine in the exacerbations of COPD due to Pseudomonasae

Mccabe, H.L.; Lind, M.J.; Wilkinson, S.; Maraveyas, A., 2001:
Levomepromazine has efficacy in delayed chemotherapy induced emesis following platinum-based treatment

Aukst-Margetić, B.; Margetić, B.; Tosić, G.; Bilić-Prcić, A., 2004:
Levomepromazine helps to reduce sleep problems in patients with PTSD

Sgouros, J.; Neville Webb, H.; Bunton, S.; Lind, M.J.; Maraveyas, A., 2003:
Levomepromazine versus Dexamethasone with Metoclopramide in the prevention of cisplatin induced delayed emesis Preliminary results of a randomized Study

Kenneth Koe, B., 1999:

Sevestre, H.P., 2003:
Levonorgestrel releasing intrauterine device Clinicopathological correlation

Swan, C.L.; Crellin, N.K.; Chedrese, P.J., 2000:
Levonorgestrel stimulated progesterone synthesis is not altered by progesterone receptor antagonists in a stable porcine granulosa cell line

Skrumsager, B.K.; Muller, M.; Kiehr, B., 1999:
Levormeloxifene Safety and pharmacokinetics in young versus elderly postmenopausal women

Hey, A.; Norgaard, K., 2000:
Levormeloxifene a non-steroid partial estrogen receptor agonist inhibits growth of MCF-7 breast tumors by arresting cells in G1-phase of the cell cycle

Hotchkiss, C.E.; Stavisky, R.; Nowak, J.; Kaplan, J., 1999:
Levormeloxifene prevents increased bone turnover and trabecular bone loss following ovariectomy in cynomolgus monkeys

Cleland, J.G.F.; McGowan, J., 2002:
Levosimendan: a new era for inodilator therapy for heart failure?

Innes, C.A.; Wagstaff, A.J., 2003:
Levosimendan: a review of its use in the management of acute decompensated heart failure

Braun, J-P.; Döpfmer, U.; Kastrup, M.; Roots, I.; Borges, A.; Schneider, M.; Dohmen, P.; Kox, W.; Spies, C., 2004:
Levosimendan. Clinical indications of a new vasoactive substance

Toller, W.G.; Pagel, P.S.; Kersten, J.R.; Warltier, D.C., 2000:
Levosimendan Treatment of heart failure, calcium sensitizer, KATP channel activator -OR-1259 SimdaxTM

Toller, W.G.; Montgomery, M.W.; Kersten, J.R.; Pagel, P.S.; Warltier, D.C., 1999:
Levosimendan decreases myocardial infarct size via activation of adenosine triphosphate Dependent potassium channels

Delle Karth, G.; Heinz, G., 2004:
Levosimendan in cardiology and intensive care medicine

Franco, F.; Goncalves, F.; Castro, G.; Morais, M.E.ilia; Andrade, C.; Goncalves, L.; Freitas, M.; Providencia, L., 2003:
Levosimendan is beneficial in diabetics with acute heart failure

Franco, F.; Goncalves, F.; Castro, G.; Morais, M.E.ilia; Andrade, C.; Goncalves, L.; Freitas, M.; Providencia, L.A., 2003:
Levosimendan is efficacious in acute heart failure independent of renal function

Franco, F.; Monteiro, P.; Correia, J.; Roque, C.; Goncalves, F.; Castro, G.; Goncalves, L.; Freitas, M.; Providencia, L.A., 2004:
Levosimendan is safe and effective in patients with severe low cardiac output heart failure and critical hypotension

Maytin, M.; Ito, M.; Sawyer, D.B.; Slawsky, M.T., 2003:
Levosimendan protects cardiac myocytes from oxidant stress-induced apoptosis via activation of mitochondrial ATP-dependent K-channels

Rajek, A.M.; Koinig, H.; Jelen, M.; Schiferer, A.; Hutschala, D., 2003:
Levosimendan, a New Ca-Sensitizer, in Patients with Poor Left Ventricular Function Undergoing Cardiac Surgery

Distrutti, E.; Fiorucci, S.; Pensi, M.O.; Vanasia, M.; Cammilleri, F.; Morelli, A., 1999:
Levosulpiride decreases perception of rectal distention in healthy subjects and IBS patients

Mearin, F.; Rodrigo, L.; Perez Mota, A.; Balboa, A.; Jimenez, I.; Sebastian,; Paton, C., 2003:
Levosulpiride in the treatment of dysmotility like functional dyspepsia randomised double dimmed comparison with cisapride

Troshina, K.A.; Veldanova, M.V.; Mazurina, N.V.; Dedov, I.I., 2000:
Levothyroxine and potassium iodide are effective in treatment of benign solitary nodules of the thyroid

Franz, G.A.drew; Strauss, E.A.; Dimenna, P.A.; Gemma, R.L., 2003:
Levothyroxine compositions and methods

Yaylali, O.; Yuksel, D.; Kirac, F.S., 2000:
Levothyroxine treatment and bone mineral density

Nguyen, L.T.H.; Luong, K.V.Q., 2004:
Levothyroxine-induced hyperthyroidism

Martin, M.H.; Ames, M.D., 2000:
Lewis Charles Frost

Kerr, C.L.; Hanna, W.; Shaper, J.H.; Wright, W.W., 2000:
Lewis X-containing neoglycoproteins bind to zona pellucida receptors on murine sperm

Sauter, G.; Himmler, G.; Loibner, H., 2003:
Lewis Y/EpCAM co-expression in breast cancer is correlated with poor prognosis

Fitchette, A.C.therine; Cabanes Macheteau, M.; Gomord, V.; Lerouge, P.; Faye, L.; Martin, B.; Hawes, C., 2000:
Lewis a-containing N-glycans are localized in the Golgi apparatus and at the surface of plant cells

Li, C.J.n; Keh, C.C.K.; Varma, R.S.; Namboodiri, V.V., 2002:
Lewis acid catalyzed formation of tetrahydropyrans in ionic liquid

Saez, J.A.; Arno, M.; Domingo, L.R., 2003:
Lewis acid-catalyzed cycloaddition of 2- acrolein with furan Insight on the nature of the mechanism from a DFT analysis

Larock, R.C.; Hanson, M., 2001:
Lewis acid-catalyzed polymerization of biological oils and resulting polymeric materials

Rauniyar, V.; Hall, D.G., 2004:
Lewis acids catalyze the addition of allylboronates to aldehydes by electrophilic activation of the dioxaborolane in a closed transition structure

Wheeler, R.A.; Wheeler, D.S.; Grigson, P.S., 2001:
Lewis and Fischer 344 rats exhibit different responses to cocaine and morphine in the saccharin avoidance design

Haile, C.N.; Kosten, T.A., 2000:
Lewis and Fischer rats show differential effects of D1- and D2-like compounds on cocaine self-administration

Vestergaard, E.M.; Hein, H.O.; Meyer, H.W.H.; Grunnet, N.; Jorgensen, J.; Wolf, H.; Orntoft, T.F., 1999:
Lewis and secretor genotype-based reference values for tumor marker CA 19-9 and evaluation of secretor and Lewis genotyping in a Caucasian population

Hynes, S.O.; Moran, A.P., 2000:
Lewis antigen expression on outer membrane vesicles of Helicobacter pylori Implications for virulence

Sheu, B.S.; Yang, H.B.; Shiesh, S.C.; Chuang, C.H.; Wu, J.J., 2000:
Lewis antigen phenotype is a significant host factor relevant to Helicobacter pylori infection of the dyspeptic patients in Taiwan

Rasko, D.A.; Keelan, M.; Thomson, A.B.; Taylor, D.E., 2000:
Lewis antigen phenotype is altered in Helicobacter pylori isolated from asymptomatic subjects

Keelan, M.; Rasko, D.; Taylor, D.E., 2000:
Lewis antigen phenotype is altered in Helicobacter pylori isolated from gastric aspirates vs antral biopsies of asymptomatic subjects

Nogueira, A.M.F.; Marques, T.; Soares, P.; Queiroz, D.; Rocha, G.; Rocha, A.; Santos, A.; David, L.; Reis, C., 2002:
Lewis expression in childrens gastric mucosa Relationship with Helicobacter pylori infection and cagA status

Michopoulos, S.; Tsibouris, P.; Katopi, D.; Sotiropoulou, M.; Giotopoulou, V.; Balta, A.; Galanopoulos, G.; Kralios, N., 2000:
Lewis phenotype influences ulcerative colitis extent

Pouget, J.; Verschueren, A.; Azulay, J.P.ilippe; Attarian, S., 2001:
Lewis-Sumner syndrome and multifocal motor neuropathy with conduction block One single entity?

Lepper, P.M.; Laub, J.; Moericke, A.; Trautmann, M., 2002:
Lewis-type antigens in clinical Helicobacter pylori isolates

Zheng, P.Y.; Ng, H.C.; Hua, J.; Ho, B., 2000:
Lewisb expression in Helicobacter pylori does not interfere with the bacterial adhesion property in vitro

Kehe, K.; Schneider, J.; Bartling, A.; Reichl, F.X.; Kreppel, H.; Szinicz, L., 2003:
Lewisite induces apoptosis in HaCaT-cells independent from caspase activation

Sugiyama, H.; Kashihara, N.; Yamasaki, Y.; Sekikawa, T.; Makino, H., 2000:
Lewis(y) expression and renal tubular atrophy in IgA nephritis

Saito, Y.; Ruberu, N.N.; Sawabe, M.; Hiroshi, Y.; Murayama, S., 2003:
Lewy - related alpha - synucleinopathy in aging human brain

Lippa, C.F.; Schmidt, M.L.; Lee, V.M.Y.; Trojanowski, J.Q., 2001:
Lewy bodies in familial Alzheimers disease alpha-Synuclein epitope mapping parallels dementia with Lewy bodies and Parkinsons disease, but differs from multisystem atrophy

Popescu, A.; Lippa, C.F., 2001:
Lewy bodies in the amygdala alpha-Synuclein expression is increased in specific neurodegenerative diseases

Riley, David E., 2002:
Lewy body disease

Leverenz, J.B.; Bonner, L.T.; Tsuang, D.W.; Nochlin, D.; Peskind, E.R.; Kraybill, M.; Bowen, J.D.; Mccormick, W.C.; Teri, L.; Raskind, M.A.; Kukull, W.A.; Larson, E., 2003:
Lewy body pathology in community- and research-based samples of Alzheimers disease Frequency and risk factors

Wakisaka, Y.; Furuta, A.; Tanizaki, Y.; Kiyohara, Y.; IIda, M.; Iwaki, T., 2002:
Lewy body pathology in consecutive autopsies of a certain community based population

Kovari, E.; Gold, G.; Giannakopoulos, P.; Lovero, P.; Surini, M.; Bouras, C., 2000:
Lewy body pathology in different neurodegenerative diseases

Leverenz, J.B.; Tsuang, D.W.; Fishel, M.A.; Steinbart, E.; Raskind, M.A.; Nochlin, D.; Schellenberg, G.D.; Bird, T.D., 2003:
Lewy body pathology in familial Alzheimers disease A clinical-neuropathological study in ethnic Volga Germans with a PS-2 mutation or APOE epsilon4

Santacruz, K.; Pahwa, R.; Lyons, K.; Troster, A.; Handler, M.; Koller, W.; Decarli, C., 1999:
Lewy body, neurofibrillary tangle and senile plaque pathology in Parkinsons disease patients with and without dementia

Goto, Y.; Hashizume, Y.; Yoshida, M.; Konagaya, M.; Sobue, G., 2000:
Lewy-related dystrophic neurites in cerebral cortex of Parkinsons disease and diffuse Lewy body disease

Pellicano, S.; Calzone, R.; Bertuccio, A.; Ranieri, S.F.; Rombola, F.; Del Giudice, A.C.; Bertuccio, S.N., 2004:
Lewys bodies dementia - A case report

Arnott, W.L.; Chenery, H.J., 1999:
Lexical decision in Parkinsons disease A comment on Spicer, Brown, and Gorell , and McDonald, Brown, and Gorell

Ozawa, K.; Fiorentino, R.; Poeppel, D., 2003:
Lexical frequency and the M350 MEG response

Brown, T.T.; Lugar, H.M.; Coalson, R.S.; Miezin, F.M.; Petersen, S.E.; Schlaggar, B.L., 2002:
Lexical processing growing up how brain regions showing age related effects for controlled lexical tasks change across maturation

Asato, K.M.; Tsai, I.M.; Mcdaniel, M.R., 2003:
Lexicon development of appearance and texture descriptors for melted cheddar cheese

Hayakawa,F.; Ukai,N.; Nishida,J.; Kazami,Y.; Kohyama,K., 2010:
Lexicon for the sensory description of French bread in Japan

Kuhn, S.P.; Amos, A.E.; Haldeman, M.T.; Liu, C., 2002:
Lexicon-enhanced text searching for biological information in the CAS databases

D.T.nno, F.; Tavolini, I.M.; Bertoldin, R.; Curti, P.; Belmonte, P.B.; Fandella, A.; Guaitoli, P.; Cossaro, E.; D'inca, G.; Guazzieri, S., 2003:
Leydig Cell Tumours of the testis The GUONE experience

Kaponis, A.J.; Kanakas, N.; Mio, Y.; Miyagawa, I.; Sofikitis, N., 2003:
Leydig and sertoli cell secretory function in men with Y-chromosome microdeletions

Luo, L.D.; Chen, H.; Kim, J.M.n; Ghosh, R.; Zirkin, B.R., 2002:
Leydig cell aging Cyclic AMP, StAR, and the steroidogenic enzymes

Luo, L.; Chen, H.; Zirkin, B.R., 2000:
Leydig cell aging Steroidogenic acute regulatory protein and cholesterol side-chain cleavage enzyme

Dong, Q.; Hardy, M.P., 2004:
Leydig cell function in man

Williams, D.H.I.; Grayhack, J.T.; Stellmach, V.; Crawford, S.E.; Case, J.; Lee, C.; Brannigan, R.E., 2004:
Leydig cell hyperplasia and increased microvascular density in pigment epithelium-derived factor null mice testes

Seber, A.; Antoneli, Célia.Beatriz.Gianotti.; Spinola-Castro, A.Maria.; Oyafuso, M.Suheko., 2002:
Leydig cell tumor and mature teratoma: unusual non-ocular tumors associated with sexual pseudo-precocity six years after unilateral retinoblastoma

Jain, T.; VanKessel, K.; Reed, S.; Paley, P., 2000:
Leydig cell tumor, mature teratoma, and nongestational choriocarcinoma in a single ovary

Rich, M.A.; Keating, M.A., 2000:
Leydig cell tumors and tumors associated with congenital adrenal hyperplasia

D.T.nno, F.; Tavolini, I.M.tteo; Fandella, A.; Bertoldin, R.; Curti, P.; Belmonte, P.; Cossaro, E.; Guaitoli, P.; Guazzieri, S.; D'inca, G., 2003:
Leydig cell tumors of the testis Experience about 50 cases from the GUONE

Fallick, M.L.; Lin, W.W.; Lipshultz, L.I., 1999:
Leydig cell tumors presenting as azoospermia

Mooney, E.E.; Man, Y.G.; Bratthauer, G.L.; Tavassoli, F.A., 1999:
Leydig cells in Sertoli-Leydig cell tumors have a reactive rather than a neoplastic molecular profile

Liu, G.; Duranteau, L.; Carel, J.C.; Monroe, J.; Doyle, D.A.; Shenker, A., 1999:
Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor

Bakal, C.J.; Wu, C.; Finan, D.; Rottapel, R.K., 2002:
Lfc, a RhoGEF, is required for proper chromosome segregation during mitosis

Tao, T.; Lan, J.; Sweezey, N.B.; Kaplan, F., 2002:
Lgl2, a novel importin beta family protein, supports the nuclear relocation of the glucocorticoid receptor

Obray, J.B.; Long, T.R.; Brown, M.J.; Wass, C.Thomas., 2003:
Lhermitte sign associated with postdural puncture headache in a parturient

Demaerel, P.; Van Calenbergh, F.; Wilms, G., 2003:
Lhermitte-Duclos disease: a tumour or not a tumour

Reuss, A.E.; Wray, S., 2002:
Lhrh neurons express phospholipid transfer protein

Failli, V.; Rogard, M.; Besson, M.J.; Retaux, S., 2000:
Lhx9 LIM-homeodomain factor Genomic structure and expression patterns of alternatively spliced isoforms in the developing brain

Failli, V.; Pere, S.; Lledo, P.M.; Bach, I.; Retaux, S., 2001:
Lhx9alpha, a truncated LIM homeodomain factor, inhibits neuronal differentiation of PC12 cells

Li, D.K.n; Janevic, T.; Odouli, R.; Liu, L., 2003:
Li et al respond to No link between hot tubs and miscarriage

Los, G.V.; Hokin, L.E., 1999:
Li+ increases high affinity sodium-dependent glutamate uptake in human neuroblastoma cells

Abukhdeir, A.M.; Layden, B.T.; Minadeo, N.; D.F.eitas, D.M.ta, 2002:
Li+/Mg2+ competition during chronic treatment with therapeutic Li+ levels in human neuroblastoma SH-SY5Y cells

D.F.eitas, D.M.ta; Williams, N.; Geraldes, C.F.G.C., 2003:
Li+/Mg2+ competition for Mg2+-binding sites in G-proteins Implications for bipolar disorder

Layden, B.; D.F.eitas, D.E.M.ta, 2000:
Li+/Mg2+ competition in human lymphoblastoma cells

Minadeo, N.M.; Amari, L.; D.F.eitas, D.E.M.ta, 2000:
Li+Mg+2 competition and binding site determination in recombinant Gia1

Wong, B.W.; Fan, S.T.; Luk, J.M., 2003:
Li-cadherin , a potential biomarker for hepatocellular carcinoma

Garofalo, R.S.; Orena, S.J.; Torchia, A.J., 1999:
LiCl stimulates glycogen synthase and glucose transport via distinct mechanisms in 3T3-L1 adipocytes

Jin,; Thibaudeau, G., 1999:
LiCl-induced phosphoprotein involved in pigment development in the embryonic zebrafish

Kasai,M.; Ikeda,M.; Asahina,T.; Fujisawa,K., 2010:
LiDAR-derived DEM evaluation of deep-seated landslides in a steep and rocky region of Japan

Ponjee, G.A.E.; Van Doorn, L.J.; Stet, E.; Quint, W.G.V., 2000:
LiPA Factor V Leiden/FII mutant

Bhananker, S.M.; Posner, K.L.; Domino, K.B.; Lee, L.; Cheney, F.W., 2003:
Liability Associated with Monitored Anesthesia Care ASA Closed Claims Project

Long, J.C.; Reed, S.; Robin, R.W.; Goldman, D., 2001:
Liability distribution for alcohol dependence in a Southwestern American Indian tribe

Shete, S.S.; Amos, C.I., 2001:
Liability groups in linkage analysis

Kershen, Drew L., 2003:
Liability issues related to transgene flow in agriculture

Juriloff, D.M.; Harris, M.J.; Gunn, T.M.; Wu, M.K.; Mah, D.G.; Dewell, S.L., 2001:
Liability loci for multifactorial cleft lip and palate map to the same chromosomal locations as liability loci for multifactorial neural tube closure defects in mice

Vanyukov, M.M.; Tarter, R.E.; Kirisci, L.; Kirillova, G.P.; Maher, B.S.; Clark, D.B., 2003:
Liability to substance use disorders: 1. Common mechanisms and manifestations

Vanyukov, M.M.; Kirisci, L.; Tarter, R.E.; Simkevitz, H.F.; Kirillova, G.P.; Maher, B.S.; Clark, D.B., 2003:
Liability to substance use disorders: 2. A measurement approach

Kanda, K.; Sato, S.; Kemuriyama, T., 2000:
Liability to temporal summation of the flexor reflex in aged rats

Koenig, B.; Ivankovic, B.; Schleff, R.; Mack, M., 1999:
Liaison free PSA-an automated chemiluminescent immunoassay for the determination of free prostate specific antigen

Forbes, R.; Craig, J.; Callender, M.; Patterson, V., 2004:
Liaison neurology for acute medical admissions

Pignatello, M.A.; Kauffman, F.C.; Levin, A.A., 2002:
Liarozole markedly increases all trans-retinoic acid toxicity in mouse limb bud cell cultures A model to explain the potency of the aromatic retinoid -4- -1-propenyl benzoic acid

Taverne, Louis, 2004:
Libanechelys bultyncki gen et sp nov, a new primitive eel from the marine Cenomanian of Lebanon

Joedicke, R.; Van Tol, J., 2003:
Libellula aenea Linnaeus, 1758 and L flavomaculata Vander Linden, 1825 Proposed conservation of usage of the specific names by the replacement of the lectotype of L aenea with a newly designated lectotype

Bolt, Hermann A., 2004:
Liber testimonii

Fok,M.; XuNaiYin, 2010:
Liberalization and regulation of varieties and seed markets in China Bt-cotton case study

Bhorade, S.M.; Jordan, A.M.; Vigneswaran, W.T.; Garrity, E.R., 2003:
Liberalization of donor criteria does not compromise outcomes three years after lung transplantation

Donini, A.; Baccarani, U.; Lavaroni, S.; Dialti, V.; Adami, V.; Risaliti, A.; Cautero, N.; Degrassi, A.; Bresadola, F., 2001:
Liberase HI enzyme versus collagenase type P for porcine hepatocyte isolation

Hahn, W.E.; Arnold, C.A., 2002:
Liberating intracellular matter from biological material

Foust, G.N.; Potter, W.A., 2000:
Liberation from mechanical ventilation Efficacy of readiness testing via a two step pressure support breathing challenge with noninvasive positive pressure ventilation as a contingency plan

Neubert, R.H.H.; Pötzsch, A., 2004:
Liberation of hydrocortisone acetate from different commercial formulations

Aizenman, E.; Pal, S.; Hartnett, K.; Nerbonne, J.M.; Levitan, E.S., 2003:
Liberation of intracellular zinc in neuronal apoptosis Role of KV21-encoded potassium channels

Everett, S.A.; Stratford, M.R.L.; Patel, K.B.; Naylor, M.A.; Murray, G.I.; Wardman, P., 2000:
Liberation of nitric oxide from stable pro-drugs by cytochrome P450 mono-oxygenases expressed in tumours

Kikugawa, K.; Hiramoto, K., 2001:
Liberation of reactive nitrogen oxide species from N-nitrosamine by ultraviolet light irradiation

Hsu, Eric, 2004:
Liberty Hyde Bailey Pioneer of palm systematics

Damann, K.E.; Tubajija, K.M., 2002:
Liberty TM herbicide reduces aflatoxin contamination in corn

Kridli, R.T.; Shaker, M.M.mani; Abdullah, A.Y.; Sada, I., 2002:
Libido and biological parameters of mature Awassi, Awassi x Charollais and Awassi x Romanov rams

Wyllie, M.G., 2003:
Libido and desire: join the club?

Santos, M.D.; Torres, C.A.A.; Guimaraes, J.D.; Ruas, J.R.M.; Carvalho, G.R., 2003:
Libido of nellore bulls Effect of bull Cow ratio on pregnancy rate

Gelgand, E.A.; Sibbitt, W.G.; Roldan, C.A., 2003:
Libman-Sacks vegetations are associated with cerebrovascular disease in patients with systemic lupus erythematosus

Boldi, A.M., 2004:
Libraries from natural product-like scaffolds

Berube, M.; Ciobanu, L.C.; Poirier, D., 2001:
Libraries of 16beta-estradiol derivatives as inhibitors of steroid sulfatase and type 1 17beta-hydroxysteroid dehydrogenase

Gilon, C.; Hornik, V., 2000:
Libraries of backbone-cyclized peptidomimetics

Gao, J.; Strässler, C.; Tahmassebi, D.; Kool, E.T., 2002:
Libraries of composite polyfluors built from fluorescent deoxyribosides

Southern, E.M.llor; Shchepinov, M.S.rgeevich; Housby, J.N.cholas; Hamilton, A.L.wis; Elder, J.K.nneth, 2004:
Libraries of oligomers labeled with different tags

Szostak, J.W.; Roberts, R.W.; Liu, R., 2001:
Libraries of protein encoding RNA-protein fusions

Sud, M.; Hebert, N.; Sage, C., 2002:
Library design R-group ranking for favorable ADME characteristics

Poupon, E.; Duval, R.; Lewin, G.; Hocquemiller, R., 2003:
Library of squamocin analogs by click chemistry

Ichikawa, E.; Platts Mills, T.A.E.; Wheatley, L.M., 1999:
Library screening and recombinant expression A new approach to the question of allergic response to bacterial proteins

Treco, D.A.; Miller, A.M., 1999:
Library screening method

Schmuttenmaer, C.; Venables, D.S.; Huang, K., 2002:
Librational motion of water confined within reverse micelles and in proteins

Lonetto, Michael Arthur, 2001:

Lonetto, Michael Arthur, 2001:
LicD1 polypeptides

Lafuente, M.; Roca, V.; Martin Mateo, M.P.; Carbonell, E.; Estrada, A., 2000:
Lice and ticks parasitizing Audouins gull Larus audouinii Payraudeau, 1826 in the Chafarinas Islands

Altschuler, Deborah Z., 2003:
Lice comb cleaning device

Kiel, J.S.; Ping, J.H., 2002:
Lice removing composition

Caplan, L.R., 2000:
Lice, fleas, and strokes

Frank, S.; Ebert, A.D., 2001:
License to kill tumors: how much hope is justified for trail?

Lygerou, Z.; Nurse, P., 2000:
License withheld Geminin blocks DNA replication

Mehta, J.M., 2001:
Licensing IP to ensure accessibility to vaccines and other immunisation-related products

Good, A.M.; Strachan, F.; Oliver, J.J.; Kelly, C.A.; Bateman, D.N., 2002 :
Licensing decisions and TOXBASE Evaluating the effect of restricted indications for thioridazine on its use in acute overdose

Takisawa, Haruhiko, 2001:
Licensing of DNA replication in the proliferation of eukaryotic cells

Miller, C.E.; Baty, B.; Berkheim, L.; Cantwell, M.; Dent, K.; Mcdonald, J.; Mensching, L.; Palumbos, J.; Pho, L.; Solomon, C.; Venne, V.; Hafen, B.; Rosenthal, E.; Poss, A., 2001:
Licensure of genetic counselors Success in Utah

Arosio, G.; Pozzoli, M.L.isa; Scarselli, S., 2002:
Lichen Biodiversity in the surroundings of a Thermo-Electric Power Station in the province of Lodi

Seaward, M.R.D., 2003:
Lichen Herbarium at The Manchester Museum 1 Collectors

Isocrono, D.; Matteucci, E.; Allisiardi, C.; Piervittori, R., 2003:
Lichen biodiversity in the Maritime Alps studies on substrate specificity in the Valasco Valley

Scerbo, R.; Possenti, L.; Lampugnani, L.; Ristori, T.; Barale, R.; Barghigiani, C., 1999:
Lichen biomonitoring of trace element contamination and air quality assessment in Livorno Province

Scerbo, R.; Ristori, T.; Possenti, L.; Lampugnani, L.; Barale, R.; Barghigiani, C., 2002:
Lichen biomonitoring of trace element contamination and air quality assessment in Pisa Province

Coxson, D.S.; Marsh, J., 2001:
Lichen chronosequences in lodgepole pine forests of northern interior British Columbia

Caniglia, G.M.ria; Grillo, M., 2001:
Lichen colonization on the archeological area of Megara Iblea

Will Wolf, Susan, 2002:
Lichen community indicators of old-growth characteristics in western Great Lakes managed forests

Burmeister, M.S.; Deline, C.S.; Greenwood Deline, L.; Kimmey, J.A.; Schrage, K.M.; Wachholder, B.E.; Meiners, S.J.; Methven, A.S., 2003:
Lichen community structure on gravestones A preliminary investigation

Mccutcheon, D.E., 2001:
Lichen flora of county Durham Supplement 1

Seaward, M.R.D.; Henderson, A., 1999:
Lichen flora of the West Yorkshire conurbation Supplement VI

Trenbirth,H.E.; Matthews,J.A., 2010:
Lichen growth rates on glacier forelands in southern Norway preliminary results from a 25-year monitoring programme

D.Vries, Bernard, 2003:
Lichen inventory of the Crooked Lake Fen Nature Sanctuary

Lo, P.Y.; Tzung, T.Y., 2000:
Lichen myxedematosus in a patient with hepatocellular carcinoma

Panda, S.; Malakar, S., 2003:
Lichen nitidus-like allergic contact dermatitis - a clinicopathological study

Metin, A.; Calka, O.; Ugras, S., 2001:
Lichen planopilaris coexisting with erythema dyschromicum perstans

Gross, S.A.; Katz, S.; Garofalo, J.A.; Anhalt, G.J., 2003:
Lichen planus esophagitis mimicking intractable erosive esophagitis

Daramola, O.O.M.; Ogunbiyi, A.O.; George, A.O., 2002:
Lichen planus following hepatitis B vaccination in an African girl

Ukleja, A.; Achem, S.R., 2000:
Lichen planus of the esophagus mimicking peptic stricture

Baran, R., 2000:
Lichen planus of the nails mimicking the yellow nail syndrome

Sangvichien, E.; Homchantara, N.; Mongkolsuk, P.; Boonprakob, K., 2000:
Lichen research in Thailand

Hunger, R.E.; Yawalkar, N.; Kappeler, A.; Mueller, C.; Braathen, L.R., 2004:
Lichen sclerosus Detection of activated cytotoxic cells in the cellular infiltrates

Barbagli, G.; Palminteri, E.; Vallesciani, S.; Lazzeri, M.; Turini, D., 2004:
Lichen sclerosus and penile carcinoma

Barbagli, G.; Palminteri, E., 1999:
Lichen sclerosus involving anterior urethra

Crow, J.C.; Rolfe, K.J.; Levine, T.S.; Reid, W.; Maclean, A.B.; Perrett, C.W., 2000:
Lichen sclerosus, squamous hyperplasia and differentiated VIN A pathway to vulval malignancy

Yashar, S.; Han, K.F.; Haley, J.C., 2004:
Lichen sclerosus-lichen planus overlap in a patient with hepatitis C virus infection

Sorgentini, C.; Allevato, M.A.; Dahbar, M.; Cabrera, H., 2004:
Lichen striatus in an adult: successful treatment with tacrolimus

Hansen, E.S., 2001:
Lichen-rich soil crusts of arctic Greenland

Li, X.L.ang; Ljungdahl, L.G.; Chen, H., 2000:
Lichenase and coding sequences

Kocourkova, Jana, 2000:
Lichenicolous fungi of the Czech Republic

Ooi, B.C.; Phua, K.B.; Lee, B.L.; Tan, C.E.; Ng, I.S.; Quak, S.H., 2001:
Lichenification and enlargement of hands and feet: a sign of progressive familial intrahepatic cholestasis with normal gamma-glutamyl-transpeptidase

Ooi, B.C.; Phua, K.B.; Tan, V.C.C., 2000:
Lichenification and hypertrophy of hands and feet A characteristic sign of Byler disease

Magro, C.M.; Pilavdzic, D.; Crowson, A.N., 1999:
Lichenoid and granulomatous dermatitis A novel cutaneous reaction pattern

Canonne-Courivaud, D.; Carpentier, O.; Dejobert, Y.; Hachulla, E.; Delaporte, E., 2003:
Lichenoid drug reaction to leflunomide

Lim, D.; Muir, J., 2002:
Lichenoid eruption to STI 571

Horiuchi, Y., 2001:
Lichenoid eruptions due to ursodeoxycholic acid administration

Corazza, M.; Zampino, M.Rosaria.; Montanari, A.; Pagnoni, A.; Virgili, A., 2002:
Lichenoid reaction from a permanent red tattoo: has nickel a possible aetiologic role?

Rubegni, P.; Fimiani, M.; de Aloe, G.; Andreassi, L., 2000:
Lichenoid reaction to temporary tattoo

Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file: